Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncoumarin 7-hydroxylase activity

CYP2A6 CYP2A7 CYP2A13

1.82e-0632453GO:0008389
GeneOntologyMolecularFunctioncytoskeletal motor activity

MYO6 MYO7A MYO9B KIF15 MYO18B DNAH9 KIF6 MYO1H MYO1B

1.52e-051182459GO:0003774
GeneOntologyMolecularFunctionprotease binding

INS BRCA2 NFRKB OS9 HSPG2 FN1 CD177 DVL3 LDLR SERPINC1 PRKN

1.52e-0518124511GO:0002020
GeneOntologyMolecularFunctionATP-dependent activity

MYO6 RTEL1 MYO7A MYO9B MCM4 MCM6 HSPA13 UBA1 KIF15 DHX29 DNAH9 HSPA4 KIF6 MYO1H MYO1B UBA3 YTHDC2 MORC2 ATP10A CHTF18 ATP2B4

2.44e-0561424521GO:0140657
GeneOntologyMolecularFunctionactin binding

MYLK MYO6 MYO7A MYO9B VPS16 ACTN3 PTK2 MYO18B NOS2 MYO1H CAMSAP3 MYO1B MIB2 AFAP1 CORO6 PRKN PALLD

9.46e-0547924517GO:0003779
GeneOntologyMolecularFunctionmicrofilament motor activity

MYO6 MYO7A MYO9B MYO1H MYO1B

9.63e-05382455GO:0000146
GeneOntologyMolecularFunctioncalmodulin binding

MYLK MYO6 MYO7A MYO9B OBSCN SPATA17 NOS2 CACNA1A CAMSAP3 MYO1B ATP2B4

1.34e-0423024511GO:0005516
GeneOntologyMolecularFunctionmethionine adenosyltransferase activity

MAT1A MAT2A

1.50e-0422452GO:0004478
GeneOntologyMolecularFunctioncysteine-type exopeptidase activity

SCRN1 BLMH SCRN2

2.05e-04102453GO:0070004
GeneOntologyMolecularFunctioncytoskeletal protein binding

MYLK MYO6 MYO7A MYO9B DLGAP5 OBSCN VPS16 ACTN3 DYSF PTK2 ALMS1 KIF15 BRCA2 PTPRN MYO18B NOS2 KIF6 MYO1H GTSE1 CAMSAP3 MYO1B MIB2 JAKMIP3 AGBL4 AFAP1 CORO6 PRKN PALLD

2.07e-04109924528GO:0008092
GeneOntologyMolecularFunctionactin filament binding

MYO6 MYO7A MYO9B VPS16 ACTN3 MYO18B MYO1H CAMSAP3 MYO1B CORO6

5.17e-0422724510GO:0051015
GeneOntologyMolecularFunctionguanyl-nucleotide exchange factor activity

GBF1 OBSCN ARHGEF11 ARHGEF37 DOCK6 RABIF RAPGEF4 KNDC1 LAMTOR3 PLCE1

5.92e-0423124510GO:0005085
GeneOntologyMolecularFunctiontransition metal ion binding

CYP2A6 CYP2A7 CYP2A13 MYO9B INS ZNF184 TRIM29 TRIP12 TCHHL1 MMP14 MMP15 NUP153 RABIF PNMA3 FN1 XDH MIB2 MORC2 AGBL4 LIG3 TH TRIM56 TLL2 ZNF75D PRKN KDM7A RNF207 PDZRN3

7.22e-04118924528GO:0046914
GeneOntologyMolecularFunctiontetrahydrobiopterin binding

NOS2 TH

8.85e-0442452GO:0034617
GeneOntologyBiologicalProcessimport into cell

MYO6 MYO7A INS SIGLEC5 ARHGEF11 DYSF MYCBPAP PTK2 EHD3 ALMS1 KCNH2 C3 C4A TRPV3 C4B CACNA1A HSPG2 RALB CD177 MYO1H SIGLEC14 MYO1B LDLR GPR107 SLC15A4 LRP6 RAB7B PRKN ATP2B4 CDH13

8.21e-06107424030GO:0098657
GeneOntologyCellularComponentmyosin complex

MYO6 MYO7A MYO9B MYO18B MYO1H MYO1B

6.39e-05592446GO:0016459
DomainIQ

MYO6 MYO7A MYO9B OBSCN SPATA17 MYO18B IQCE MYO1B

3.96e-06712448PF00612
DomainCyt_P450_E_grp-I_CYP2A-like

CYP2A6 CYP2A7 CYP2A13

8.73e-0642443IPR008067
DomainIQ

MYO6 MYO7A MYO9B OBSCN SPATA17 MYO18B IQCE MYO1B

1.07e-05812448SM00015
DomainAnaphylatoxn_comp_syst_dom

C3 C4A C4B

2.16e-0552443IPR001840
DomainAnaphylatoxin_comp_syst

C3 C4A C4B

2.16e-0552443IPR018081
DomainIQ_motif_EF-hand-BS

MYO6 MYO7A MYO9B OBSCN SPATA17 MYO18B IQCE MYO1B

2.33e-05902448IPR000048
DomainIQ

MYO6 MYO7A MYO9B OBSCN SPATA17 MYO18B IQCE MYO1B

2.96e-05932448PS50096
DomainANATO

C3 C4A C4B

7.42e-0572443SM00104
DomainANAPHYLATOXIN_2

C3 C4A C4B

7.42e-0572443PS01178
DomainANAPHYLATOXIN_1

C3 C4A C4B

7.42e-0572443PS01177
DomainAnaphylatoxin/fibulin

C3 C4A C4B

7.42e-0572443IPR000020
DomainANATO

C3 C4A C4B

7.42e-0572443PF01821
DomainTerpenoid_cyclase/PrenylTrfase

ASIC3 C3 C4A C4B

7.53e-05182444IPR008930
DomainMacrogloblnA2_thiol-ester-bond

C3 C4A C4B

1.18e-0482443IPR019565
DomainThiol-ester_cl

C3 C4A C4B

1.18e-0482443PF10569
DomainMacrogloblnA2_CS

C3 C4A C4B

1.18e-0482443IPR019742
DomainMYOSIN_MOTOR

MYO6 MYO7A MYO9B MYO18B MYO1B

1.29e-04382445PS51456
DomainMyosin_head_motor_dom

MYO6 MYO7A MYO9B MYO18B MYO1B

1.29e-04382445IPR001609
DomainMyosin_head

MYO6 MYO7A MYO9B MYO18B MYO1B

1.29e-04382445PF00063
DomainMYSc

MYO6 MYO7A MYO9B MYO18B MYO1B

1.29e-04382445SM00242
DomainADOMET_SYNTHASE_CS

MAT1A MAT2A

1.70e-0422442IPR022631
DomainS-AdoMet_synt_C

MAT1A MAT2A

1.70e-0422442IPR022630
DomainS-AdoMet_synthetase_sfam

MAT1A MAT2A

1.70e-0422442IPR022636
DomainS-AdoMet_synt_central

MAT1A MAT2A

1.70e-0422442IPR022629
DomainS-AdoMet_synt_N

MAT1A MAT2A

1.70e-0422442IPR022628
DomainS-AdoMet_synt_N

MAT1A MAT2A

1.70e-0422442PF00438
DomainS-AdoMet_synthetase

MAT1A MAT2A

1.70e-0422442IPR002133
DomainS-AdoMet_synt_M

MAT1A MAT2A

1.70e-0422442PF02772
DomainS-AdoMet_synt_C

MAT1A MAT2A

1.70e-0422442PF02773
DomainADOMET_SYNTHASE_1

MAT1A MAT2A

1.70e-0422442PS00376
DomainADOMET_SYNTHASE_2

MAT1A MAT2A

1.70e-0422442PS00377
DomainIg_I-set

MYLK OBSCN MDGA2 CD101 ADGRF5 HSPG2 SIGLEC14 MYOM2 PALLD ALPK2

2.05e-0419024410IPR013098
DomainI-set

MYLK OBSCN MDGA2 CD101 ADGRF5 HSPG2 SIGLEC14 MYOM2 PALLD ALPK2

2.05e-0419024410PF07679
DomainA2M

C3 C4A C4B

2.47e-04102443PF00207
DomainA2M_N_2

C3 C4A C4B

2.47e-04102443IPR011625
DomainA2M_comp

C3 C4A C4B

2.47e-04102443IPR011626
DomainA2M_recep

C3 C4A C4B

2.47e-04102443PF07677
DomainA2M_comp

C3 C4A C4B

2.47e-04102443PF07678
DomainA2M_N_2

C3 C4A C4B

2.47e-04102443PF07703
DomainA2M_N

C3 C4A C4B

2.47e-04102443PF01835
DomainA2M_N

C3 C4A C4B

2.47e-04102443IPR002890
DomainA-macroglobulin_rcpt-bd

C3 C4A C4B

2.47e-04102443IPR009048
DomainALPHA_2_MACROGLOBULIN

C3 C4A C4B

2.47e-04102443PS00477
DomainMacroglobln_a2

C3 C4A C4B

2.47e-04102443IPR001599
DomainPeptidase_C69

SCRN1 SCRN2

5.06e-0432442IPR005322
DomainPeptidase_C69

SCRN1 SCRN2

5.06e-0432442PF03577
DomainLaminin_G

COL21A1 HSPG2 FAT3 COL18A1 SLIT1

9.52e-04582445IPR001791
DomainDUF3377

MMP14 MMP15

1.00e-0342442PF11857
Domain-

C3 C4A

1.00e-03424421.20.91.20
DomainRubredoxin-type_fold

MCM4 MCM6

1.00e-0342442IPR004039
DomainPept_M10A_metallopeptidase_C

MMP14 MMP15

1.00e-0342442IPR021805
Domain-

MCM4 MCM6

1.00e-03424422.20.28.10
DomainUBQ-activ_enz_E1_CS

UBA1 UBA3

1.00e-0342442IPR018074
DomainUBQ-activ_enz_E1_Cys_AS

UBA1 UBA3

1.00e-0342442IPR033127
DomainIGc2

MYLK OBSCN SIGLEC5 MDGA2 ADGRF5 HSPG2 SIGLEC14 MYOM2 PALLD ALPK2

1.08e-0323524410SM00408
DomainIg_sub2

MYLK OBSCN SIGLEC5 MDGA2 ADGRF5 HSPG2 SIGLEC14 MYOM2 PALLD ALPK2

1.08e-0323524410IPR003598
DomainC345C

C3 C4A C4B

1.31e-03172443SM00643
DomainUBA_E1_Cys

UBA1 UBA3

1.66e-0352442IPR019572
DomainUBA_e1_thiolCys

UBA1 UBA3

1.66e-0352442PF10585
DomainUBIQUITIN_ACTIVAT_1

UBA1 UBA3

1.66e-0352442PS00536
DomainUBIQUITIN_ACTIVAT_2

UBA1 UBA3

1.66e-0352442PS00865
DomainNTR

C3 C4A C4B

1.83e-03192443PF01759
DomainNetrin_module_non-TIMP

C3 C4A C4B

1.83e-03192443IPR018933
PathwayWP_COMPREHENSIVE_IL17A_SIGNALING

SERBP1 MYLK MCM4 MCM6 BLMH MKI67 C3 MMP14 FN1

1.24e-051101829MM16642
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

PTK2 ITPR1 FANCA TYK2 CASKIN2 C4A C4B PPIP5K2 QSOX2 EEFSEC ATN1 CAMSAP3 YTHDC2 MIB2 ANKRD50 MORC2 LIG3 SMG8 TSR1 CDK13 CHTF18 QSER1 PATJ PALLD PLCE1

1.07e-116502482538777146
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

SERBP1 USP9X DLGAP5 MCM4 MCM6 TRIM29 TRIP12 UBA1 MKI67 DHX29 NUP153 NRBP1 PNN GTSE1 CAMSAP3 NUP88 RRP8 MORC2 GTF3C2 CDK13 PALLD EPHA1

1.69e-115032482216964243
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

USP9X VPS16 PTK2 ITIH3 DMXL1 ITPR1 SUPT6H NFRKB C3 DHX29 HSPA4 CACNA1A FN1 CAMSAP3 YTHDC2 MORC2 TRIM56 SLIT1 RPL7A

1.87e-094752481931040226
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

GBF1 MAT2A MCM4 MCM6 AASDHPPT PSMD12 TYK2 PTPRA TXNDC16 OS9 C3 MMP14 DHX29 HSPA4 QSOX2 NUP153 KPNA5 NRBP1 SRSF5 NUP88 RANBP9 TTC27 YTHDC2 ANKRD50 CSE1L ESPL1 RPL7A

2.21e-099742482728675297
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MYO6 MYO9B MAT2A DLGAP5 MCM4 MCM6 VPS16 TRIP12 PTK2 BLMH UBA1 MKI67 MMP14 DHX29 HSPA4 FN1 PNN IARS1 RANBP9 TTC27 MYO1B WDR74 LIG3 SMG8 CSE1L OXCT1 GTF3C2 CHTF18 CTNNBL1 SNRPD2 PALLD RPL7A

3.17e-0913532483229467282
Pubmed

Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.

USP9X MCM4 MCM6 TRIP12 ITPR1 SUPT6H MKI67 DHX29 HSPA4 NUP153 WEE1 NUP88 YTHDC2 RRP8 SMG8 GTF3C2 CHTF18 ESPL1

3.57e-094402481834244565
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

MYO6 MYO7A USP9X OBSCN ARHGEF11 DYSF TRIP12 KIF15 C4A C4B FN1 RAPGEF4 CAMSAP3 YTHDC2 RRP8 MORC2 NSUN7 WDR74 MYOM2

3.91e-094972481936774506
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

SERBP1 MYO6 USP9X MAT2A MCM4 PSMD12 CLCC1 UBA1 DHX29 HSPA4 NUP153 IARS1 MYO1B YTHDC2 ANKRD50 GRIP1 FAM171A1 CSE1L LRP6 PATJ PALLD RPL7A

9.87e-097082482239231216
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

TRERF1 GBF1 DLGAP5 MCM4 BCOR TRIP12 UBA1 NFRKB MKI67 DHX29 NUP153 ATN1 SRSF5 PNN WEE1 GTSE1 CAMSAP3 YTHDC2 MORC2 GTF2IRD1 CDK13 CHTF18 ESPL1

1.03e-087742482315302935
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

SNX4 USP9X BCKDHA PSMD12 BCOR CLCC1 ITPR1 BLMH UBA1 TOX4 PTPRA SMG7 KIF15 PTPRN CASKIN2 PLCL2 MKI67 NUP153 CAMSAP3 TTC27 MYO1B FAM171A1 CSE1L TSR1 LRP6 SNRPD2 ATP2B4

1.05e-0810492482727880917
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

SERBP1 MYO6 MYO7A USP9X SCRN1 ACTN3 ARHGEF11 EHD3 UBA1 PTPRA C4A C4B DHX29 HSPA4 CACNA1A SRSF5 FN1 IARS1 RAPGEF4 CAMSAP3 YTHDC2 AGBL4 PPP2R2C AFAP1 CSE1L CRACDL LGI3 KNDC1 CORO6 SNRPD2 ATP2B4 RPL7A

1.20e-0814312483237142655
Pubmed

Membrane-type MMPs are indispensable for placental labyrinth formation and development.

MMP14 MMP15 HSPG2 FN1 COL18A1

3.36e-0814248520858856
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

SERBP1 MYO9B BCKDHA TRIP12 TOX4 MKI67 DHX29 EEFSEC SRSF5 PNN AGGF1 YTHDC2 RRP8 WDR74 LIG3 CSE1L GTF3C2 TSR1 CDK13 ESPL1 SNRPD2 RPL7A

3.38e-087592482235915203
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

SERBP1 USP9X MCM4 MCM6 PSMD12 TRIP12 SUPT6H MKI67 HSPA4 NUP153 SRSF5 FN1 PNN NUP88 MYO1B YTHDC2 RRP8 CSE1L TSR1 RPL7A

6.01e-086532482022586326
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

PDE4A GBF1 MYO7A MYO9B OBSCN FHIP1B ARHGEF11 DYSF FANCA TYK2 BMP4 KCNH2 MMP14 DOCK6 IQCE HSPG2 KHNYN GTSE1 MIB2 MLXIP GTF2IRD1 LDLR C2CD2 CDK13 HMGXB3 ESPL1

1.17e-0711052482635748872
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

SERBP1 GBF1 MYO6 USP9X MAT2A MCM4 MCM6 PSMD12 BLMH UBA1 SUPT6H MKI67 MYO18B DHX29 HSPA4 NUP153 SRSF5 PNN IARS1 NUP88 MYO1B YTHDC2 LIG3 CSE1L GTF3C2 TSR1 CTNNBL1 MPHOSPH8 SNRPD2 RPL7A

1.32e-0714252483030948266
Pubmed

Nr2f1 heterozygous knockout mice recapitulate neurological phenotypes of Bosch-Boonstra-Schaaf optic atrophy syndrome and show impaired hippocampal synaptic plasticity.

MYO7A MMP14 MMP15 HSPG2

1.73e-078248431600777
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DLGAP5 SCRN1 BCOR SMG7 CASKIN2 SUPT6H PPIP5K2 DOCK6 IQCE ANKRD50 GPR107 AFAP1 GTF3C2 TSR1 HMGXB3 KDM7A ESPL1

3.12e-075292481714621295
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

SERBP1 MYO6 MYO9B MAT2A MCM4 MCM6 PSMD12 TRIP12 BMP4 MKI67 HSPA4 ATN1 SRSF5 PNN PPFIBP2 IARS1 RANBP9 DVL3 TTC27 MYO1B LIG3 CSE1L TSR1 CHTF18 PATJ SNRPD2 RPL7A

3.42e-0712472482727684187
Pubmed

Lack of the steroid 15 alpha-hydroxylase gene (Cyp2a-4) in wild mouse strain Mus spretus: rapid evolution of the P450 gene superfamily.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324838188299
Pubmed

Comparison of hamster and mouse reveals interspecies differences in the regulation of hepatic CYP2A isozymes.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324838250953
Pubmed

The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324832703500
Pubmed

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.

C3 C4A C4B

3.58e-07324838524789
Pubmed

Immune complex glomerulonephritis in C4- and C3-deficient mice.

C3 C4A C4B

3.58e-07324839461092
Pubmed

Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.

CYP2A6 CYP2A7 CYP2A13

3.58e-073248322217847
Pubmed

Regulation of the B cell response to T-dependent antigens by classical pathway complement.

C3 C4A C4B

3.58e-07324838752901
Pubmed

Chromosomal mapping, isolation, and characterization of the mouse xanthine dehydrogenase gene.

C4A C4B XDH

3.58e-07324837835888
Pubmed

Complement genes contribute sex-biased vulnerability in diverse disorders.

C3 C4A C4B

3.58e-073248332499649
Pubmed

Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324832733794
Pubmed

Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): role of residue-209 in determining steroid-cytochrome P-450 interaction.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324838484736
Pubmed

Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.

C3 C4A C4B

3.58e-073248314500686
Pubmed

Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes.

C3 C4A C4B

3.58e-073248337234916
Pubmed

Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.

CYP2A6 CYP2A7 CYP2A13

3.58e-073248324045421
Pubmed

Mouse steroid 15 alpha-hydroxylase gene family: identification of type II P-450(15)alpha as coumarin 7-hydroxylase.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324832765478
Pubmed

Sexual dimorphism of testosterone 15 alpha-hydroxylase mRNA levels in mouse liver. cDNA cloning and regulation.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324832415518
Pubmed

Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.

C3 C4A C4B

3.58e-07324839218619
Pubmed

Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17.

C3 C4A C4B

3.58e-0732483681746
Pubmed

Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.

CYP2A6 CYP2A7 CYP2A13

3.58e-073248331645370
Pubmed

A trans-acting locus regulates transcriptional repression of the female-specific steroid 15 alpha-hydroxylase gene in male mice.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324838297477
Pubmed

Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.

CYP2A6 CYP2A7 CYP2A13

3.58e-073248322890016
Pubmed

Role of complement in a murine model of peanut-induced anaphylaxis.

C3 C4A C4B

3.58e-073248323182714
Pubmed

Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma.

C3 C4A C4B

3.58e-073248335017157
Pubmed

Reciprocal regulation of sex-dependent expression of testosterone 15 alpha-hydroxylase (P-450(15 alpha)) in liver and kidney of male mice by androgen. Evidence for a single gene.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324833346244
Pubmed

In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.

C3 C4A C4B

3.58e-073248321723612
Pubmed

Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria.

C3 C4A C4B

3.58e-07324839829481
Pubmed

Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.

C3 C4A C4B

3.58e-073248316893076
Pubmed

Cerium-induced strain-dependent increase in Cyp2a-4/5 (cytochrome P4502a-4/5) expression in the liver and kidneys of inbred mice.

CYP2A6 CYP2A7 CYP2A13

3.58e-07324831417950
Pubmed

Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli.

C3 C4A C4B

3.58e-073248311433344
Pubmed

Highly homologous mouse Cyp2a4 and Cyp2a5 genes are differentially expressed in the liver and both express long non-coding antisense RNAs.

CYP2A6 CYP2A7 CYP2A13

3.58e-073248332987105
Pubmed

Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.

SERBP1 USP9X MAT2A MCM4 MCM6 PSMD12 ACTN3 BCOR UBA1 TOX4 SRSF5 PNN IARS1 MYO1B CSE1L OXCT1 CDK13 SNRPD2 RPL7A

3.75e-076652481930457570
Pubmed

Impaired mast cell-dependent natural immunity in complement C3-deficient mice.

C3 C4A C4B

1.43e-06424839367154
Pubmed

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo.

C3 C4A C4B

1.43e-064248310934224
Pubmed

Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first.

C3 C4A C4B

1.43e-06424838015436
Pubmed

The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.

C3 C4A C4B

1.43e-064248315102802
Pubmed

Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells.

C3 C4A C4B

1.43e-064248316304047
Pubmed

Functional analysis of Ficolin-3 mediated complement activation.

C3 C4A C4B

1.43e-064248321085669
Pubmed

Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice.

C3 C4A C4B

1.43e-06424839409643
Pubmed

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

C3 C4A C4B

1.43e-064248330301856
Pubmed

Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine zipper transcription factor DBP.

CYP2A6 CYP2A7 CYP2A13

1.43e-064248310490589
Pubmed

Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice.

CYP2A6 CYP2A7 CYP2A13

1.43e-06424831970547
Pubmed

Complement C4 is protective for lupus disease independent of C3.

C3 C4A C4B

1.43e-064248311801636
Pubmed

Intestinal reperfusion injury is mediated by IgM and complement.

C3 C4A C4B

1.43e-064248310066708
Pubmed

Induction of Siglec-FhiCD101hi eosinophils in the lungs following murine hookworm Nippostrongylus brasiliensis infection.

SIGLEC5 CD101 SIGLEC14

1.43e-064248337251384
Pubmed

Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice.

C3 C4A C4B

1.43e-064248315477230
Pubmed

Transcriptional regulation by HNF-4 of the steroid 15alpha-hydroxylase P450 (Cyp2a-4) gene in mouse liver.

CYP2A6 CYP2A7 CYP2A13

1.43e-06424839408084
Pubmed

Efficient amyloid A clearance in the absence of immunoglobulins and complement factors.

C3 C4A C4B

1.43e-064248323454183
Pubmed

The human complement system: assembly of the classical pathway C3 convertase.

C3 C4A C4B

1.43e-06424836906228
Pubmed

A DNA methylation site in the male-specific P450 (Cyp 2d-9) promoter and binding of the heteromeric transcription factor GABP.

CYP2A6 CYP2A7 CYP2A13

1.43e-06424837565685
Pubmed

Allelic distribution of complement components BF, C4A, C4B, and C3 in Psoriasis vulgaris.

C3 C4A C4B

1.43e-064248311803045
Pubmed

Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.

C3 C4A C4B

1.43e-064248319302245
Pubmed

Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.

C3 C4A C4B

1.43e-064248318452991
Pubmed

Gene expression analysis of the embryonic subplate.

SCRN1 ITPR1 MKI67 RALB FN1 MYO1B TLE1 SLIT1 CDH9 PDZRN3

1.62e-061962481021862448
Pubmed

SR protein kinases promote splicing of nonconsensus introns.

GBF1 TRIP12 MYO18B DNAH9 NUP153 SRSF5 PNN PPFIBP2 YTHDC2 MIB2 ATP10A CDK13 PALLD

2.30e-063612481326167880
Pubmed

Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.

MYO6 MYO7A MYO9B MYO1B

2.39e-061424848022818
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

SERBP1 GBF1 MYO6 USP9X MAT2A MCM4 MCM6 PSMD12 BLMH UBA1 HSPA4 NUP153 SRSF5 IARS1 KHNYN CAMSAP3 RANBP9 MYO1B LIG3 CSE1L TSR1 PATJ SNRPD2 RPL7A

2.95e-0611492482435446349
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

MYO6 RTEL1 OBSCN BRWD3 CLCC1 PTK2 EHD3 TYK2 SMG7 SUPT6H OS9 KATNIP ARHGEF37 DOCK6 PPFIBP2 CAMSAP3 GTF2IRD1 ATP10A C2CD2 CCNG2 COL18A1 PPP2R2C CDK13 KNDC1 PRKN GREB1 QSER1 PATJ

3.21e-0614892482828611215
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

MYO7A MCM4 MCM6 BCKDHA PSMD12 EHD3 UBA1 PLCL2 C3 KATNIP MINDY4 PPIP5K2 RALB SRSF5 WEE1 IARS1 CAMSAP3 NUP88 RANBP9 DVL3 CSE1L GTF3C2 TRIM56 QSER1 LNPK SNRPD2

3.29e-0613212482627173435
Pubmed

STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.

SERBP1 MAT2A OBSCN MCM6 PSMD12 UBA1 HSPA4 SRSF5 LIG3 GTF3C2 TSR1 RPL7A

3.29e-063162481231665637
Pubmed

Complement proteins C3 and C4 bind to collagen and elastin in the vascular wall: a potential role in vascular stiffness and atherosclerosis.

C3 C4A C4B

3.54e-065248321707943
Pubmed

Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.

C3 C4A C4B

3.54e-065248315192652
Pubmed

A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.

C3 C4A C4B

3.54e-06524839382884
Pubmed

Protective T cell-independent antiviral antibody responses are dependent on complement.

C3 C4A C4B

3.54e-065248310523614
Pubmed

The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

C3 C4A C4B

3.54e-065248322689574
Pubmed

Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency.

C3 C4A C4B

3.54e-065248325039245
Pubmed

Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice.

C3 C4A C4B

3.54e-065248319710463
Pubmed

Disruption of the talin gene arrests mouse development at the gastrulation stage.

MKI67 HSPG2 FN1

3.54e-065248311084655
Pubmed

Classical and alternative complement activation on photoreceptor outer segments drives monocyte-dependent retinal atrophy.

C3 C4A C4B

3.54e-065248329743491
Pubmed

Formation of high affinity C5 convertase of the classical pathway of complement.

C3 C4A C4B

3.54e-065248312878586
Pubmed

Complement C4A Regulates Autoreactive B Cells in Murine Lupus.

C3 C4A C4B

3.54e-065248333147456
Pubmed

The generation of thymus-independent germinal centers depends on CD40 but not on CD154, the T cell-derived CD40-ligand.

C3 C4A C4B

3.54e-065248316783845
Pubmed

Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction.

C3 C4A C4B

3.54e-065248318056835
Pubmed

Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis.

C3 C4A C4B

3.54e-065248317947689
Pubmed

Predominant role for C5b-9 in renal ischemia/reperfusion injury.

C3 C4A C4B

3.54e-065248310811844
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

SERBP1 MYO6 DLGAP5 MCM4 AASDHPPT BCOR UBA1 TOX4 SMG7 ALMS1 MKI67 DHX29 HSPA4 NUP153 PNN NUP88 MYO1B YTHDC2 LIG3 PALLD RPL7A

4.15e-069342482133916271
Pubmed

Human transcription factor protein interaction networks.

TRERF1 MYO6 USP9X PSMD12 BCOR SMG7 ALMS1 NFRKB MKI67 HSPA4 SENP5 HSPG2 ATN1 PNN IARS1 NUP88 MYO1B MORC2 LIG3 CSE1L GTF3C2 TLE1 LRP6 QSER1 SNRPD2 LRIF1 FILIP1L

4.47e-0614292482735140242
Pubmed

Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.

ITIH3 C3 C4A C4B COL18A1 CSE1L SERPINC1

4.51e-0692248737343697
Pubmed

∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.

MYO6 MAT2A MCM4 MCM6 PSMD12 ACTN3 TRIM29 BLMH UBA1 C3 HSPA4 KPNA5 IARS1 TTC27 MYO1B SERPINC1 ATP2B4

4.77e-066472481726618866
Pubmed

Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.

TRIP12 MKI67 DHX29 NUP153 PNN NUP88 YTHDC2 RRP8 WDR74 TSR1 TRIM56 MPHOSPH8

5.44e-063322481225693804
Pubmed

Tagging genes with cassette-exchange sites.

USP9X MAT2A DYSF TRIP12 PTK2 DMXL1 MKI67 DHX29 GTSE1 CSE1L TSR1 KDM7A

5.96e-063352481215741177
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

SERBP1 GBF1 MYO6 ACTN3 TRIP12 ITIH3 TOX4 TCHHL1 MKI67 C4B EEFSEC VSNL1 SRSF5 FN1 MYO1B RRP8 MORC2 WDR74 COL18A1 CSE1L TSR1 CDK13 TRIM56 CTNNBL1 SNRPD2 ATP2B4

6.36e-0613712482636244648
InteractionPPP4R1L interactions

RTEL1 BCOR DMXL1 FANCA ALMS1 BRCA2 SMG8 ESPL1 LRIF1

1.20e-06872479int:PPP4R1L
InteractionCYP2A7 interactions

CYP2A6 CYP2A7 CYP2A13

1.82e-0632473int:CYP2A7
InteractionIFI16 interactions

SERBP1 MAT2A OBSCN MCM4 MCM6 PSMD12 TRIP12 UBA1 MKI67 DHX29 HSPA4 NUP153 SRSF5 PNN NUP88 YTHDC2 RRP8 WDR74 LIG3 GTF3C2 TSR1 TRIM56 PRKN MPHOSPH8 RPL7A

2.60e-0671424725int:IFI16
InteractionFBXO22 interactions

SERBP1 MYO6 MYO7A USP9X OBSCN ARHGEF11 DYSF TRIP12 KIF15 C4A C4B FN1 RAPGEF4 CAMSAP3 YTHDC2 RRP8 MORC2 NSUN7 WDR74 PRKN MYOM2

3.46e-0654024721int:FBXO22
InteractionMYH9 interactions

SERBP1 GBF1 MYLK MYO6 LAMP5 FHIP1B OS9 OTUD3 PNMA3 NRBP1 VPS37C SRSF5 FN1 GTSE1 MYO1B LDLR C2CD2 FAM171A1 AFAP1 TSR1 TRIM56 PRKN MYOM2 SNRPD2 PALLD

6.73e-0675424725int:MYH9
InteractionCBR3 interactions

SERBP1 MKI67 RABIF RANBP9 LDLR PRKN

8.64e-06402476int:CBR3
InteractionBAG2 interactions

DLGAP5 BCOR BRWD3 PTK2 TYK2 KCNH2 SUPT6H NFRKB MINDY4 PPIP5K2 NOS2 HSPA4 EVC2 FN1 SMG8 PPP2R2C GTF3C2 PRKN GREB1 QSER1 ESPL1 PALLD

9.12e-0662224722int:BAG2
InteractionSIRT6 interactions

USP9X MCM4 MCM6 BCOR TRIP12 ITPR1 FANCA SUPT6H MKI67 DHX29 HSPA4 NUP153 WEE1 FAT3 NUP88 YTHDC2 RRP8 SMG8 GTF3C2 CHTF18 ESPL1 PALLD

1.06e-0562824722int:SIRT6
InteractionC1QTNF1 interactions

COL21A1 C14orf119 CACNA1A FN1 PNN COL18A1

2.25e-05472476int:C1QTNF1
InteractionC2 interactions

SEC11C C3 C4B ERGIC3

4.62e-05172474int:C2
InteractionNCAPH2 interactions

RTEL1 ODAD4 BCOR FANCA ALMS1 BRCA2 GTSE1 SMG8 LRIF1 EPHA1

4.64e-0516924710int:NCAPH2
Cytoband19q13.2

CYP2A6 CYP2A7 CYP2A13 ZNF180 B3GNT8 PRR19 CD177 SNRPD2

3.42e-06164248819q13.2
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MYLK OBSCN MDGA2 CD101 ADGRF5 HSPG2 MYOM2 PALLD ALPK2

1.49e-051611629593
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

C3 C4A C4B

5.70e-05916231234
CoexpressionFLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN

DLGAP5 KIF15 BRCA2 PCDH11X MKI67 ADGRF5 FN1 WEE1 GTSE1 LDLR NSUN7 E2F8 ESPL1

3.59e-0819024813M761
CoexpressionHOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP

DLGAP5 MCM4 KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

2.60e-07682488M41108
CoexpressionCAIRO_HEPATOBLASTOMA_CLASSES_UP

SERBP1 DLGAP5 UNC93A MCM4 MCM6 PTK2 HSPA13 FANCA BLMH PTPRA KIF15 BRCA2 MKI67 NUP153 IARS1 GTSE1 LIG3 CSE1L ERGIC3 GTF3C2 TSR1

4.37e-0761224821M4772
CoexpressionCASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN

SNX4 SERBP1 DLGAP5 MCM4 SCRN1 PTK2 BLMH KIF15 MKI67 HSPA4 VPS37C GTSE1 TTC27 GALNT12 LDLR FAM171A1 CSE1L TSR1 CTNNBL1 ESPL1 FILIP1L

1.81e-0666924821M18635
CoexpressionONKEN_UVEAL_MELANOMA_UP

PDE4A MYO6 DLGAP5 BDH2 MCM4 BCOR PTK2 DMXL1 PTPRA C4A PPIP5K2 IARS1 RAPGEF4 NUP88 MORC2 ATP10A C2CD2 GPR107 COL18A1 OXCT1 HMGXB3 KDM7A GREB1

2.05e-0679024823M12490
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

SNX4 GBF1 MYO9B USP9X DLGAP5 TRIP12 PTK2 ITPR1 PTPRA BRCA2 PPIP5K2 NUP153 MYO1B LDLR C2CD2 FAM171A1 AFAP1 CSE1L GTF3C2 CDK13 TLE1 ATP2B4 FILIP1L PLCE1

2.34e-0685624824M4500
CoexpressionGSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP

GBF1 MYO9B TYK2 SMG7 SUPT6H OS9 SRSF5 DVL3 C2CD2 ZNF75D FILIP1L

3.35e-0619924811M9964
CoexpressionHALLMARK_E2F_TARGETS

DLGAP5 MCM4 MCM6 BRCA2 MKI67 NUP153 PNN WEE1 E2F8 CSE1L ESPL1

3.51e-0620024811M5925
CoexpressionLI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN

DLGAP5 SCRN1 MCM6 MKI67 IARS1 MLXIP LIG3 GTF3C2 GREB1 ESPL1

3.93e-0616424810M13108
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

GBF1 MYO9B MAT2A BCOR FHIP1B ITPR1 BRCA2 OS9 MYO18B HSPA4 PLXNA2 HSPG2 SRSF5 WEE1 GPR107 COL18A1 AFAP1 CSE1L TLE1 CTNNBL1 ZNF75D LNPK ADAMTS14 PDZRN3 CDH13 PLCE1

4.04e-06100924826M157
CoexpressionLEE_BMP2_TARGETS_DN

RTEL1 MAT2A MCM4 MCM6 PSMD12 FANCA DHX29 HSPA4 QSOX2 NUP153 PNN WEE1 IARS1 NUP88 UBA3 YTHDC2 RRP8 LDLR E2F8 WDR74 CSE1L TSR1 CTNNBL1 LNPK

5.89e-0690424824M2325
CoexpressionLEE_BMP2_TARGETS_DN

RTEL1 MAT2A MCM4 MCM6 PSMD12 FANCA DHX29 HSPA4 QSOX2 NUP153 PNN WEE1 IARS1 NUP88 UBA3 YTHDC2 RRP8 LDLR E2F8 WDR74 CSE1L TSR1 CTNNBL1 LNPK

8.19e-0692224824MM1068
CoexpressionPARENT_MTOR_SIGNALING_UP

CYP2A6 PDE4A GBF1 RTEL1 MYO9B MCM4 AASDHPPT PTPRA CASKIN2 SUPT6H KATNIP DOCK6 HSPA4 IQCE FN1 RANBP9 CCNG2 SLIT1

8.69e-0656724818M16909
CoexpressionDUTERTRE_ESTRADIOL_RESPONSE_24HR_UP

MAN1A1 DLGAP5 MCM4 MCM6 FANCA BRCA2 MKI67 REXO5 GTSE1 E2F8 CHTF18 GREB1 ESPL1

1.40e-0532324813M2156
CoexpressionPUJANA_BRCA2_PCC_NETWORK

MAT2A ZNF184 DLGAP5 MCM4 MCM6 FANCA BLMH BRCA2 MKI67 ATN1 PNN GTSE1 YTHDC2 LIG3 ESPL1

1.50e-0542624815M9516
CoexpressionGSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN

MYLK KHNYN RANBP9 MLXIP E2F8 CCNG2 TCP11L2 TLE1 MYOM2 ESPL1

1.65e-0519324810M6903
CoexpressionSOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP

DLGAP5 MCM4 MCM6 PSMD12 KIF15 MKI67 GTSE1 E2F8 ESPL1

1.69e-051542489M3766
CoexpressionMARSON_BOUND_BY_E2F4_UNSTIMULATED

SERBP1 RTEL1 MYO9B DLGAP5 SEC11C MCM4 MCM6 HSPA13 FANCA ALMS1 KIF15 BRCA2 NUP153 REXO5 CFAP36 GTSE1 ATP10A CCNG2 CHTF18 ESPL1

1.70e-0571424820M1744
CoexpressionDESCARTES_ORGANOGENESIS_EPENDYMAL_CELL

INS ODAD4 MYCBPAP LRGUK SPATA17 KATNIP KIF6 CFAP36 NSUN7 AGBL4 SCRN2 CRACDL

1.73e-0528224812MM3642
CoexpressionGSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP

SCRN1 EHD3 PLXNA2 RALB EVC2 XDH SCRN2 TH TLE1 MPHOSPH8

2.24e-0520024810M7503
CoexpressionGSE17721_0.5H_VS_4H_CPG_BMDC_DN

MYLK PSMD12 TOX4 MKI67 NOS2 PPFIBP2 ATP10A E2F8 SERPINC1 ALPK2

2.24e-0520024810M4125
CoexpressionPUJANA_XPRSS_INT_NETWORK

MAT2A MCM4 MCM6 BLMH BRCA2 MKI67 PNN GTSE1 ESPL1

3.37e-051682489M18811
CoexpressionGSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN

BCOR PTK2 RAPGEF4 TTC27 SI LRP6 QSER1 PATJ FILIP1L

3.37e-051682489M7007
CoexpressionSHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6

MYO7A DLGAP5 MCM4 MCM6 PSMD12 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 CSE1L TSR1 QSER1 LRIF1

3.46e-0545824815M8520
CoexpressionFAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2

MYLK MYO6 PTK2 ITPR1 DOCK6 FN1 PPFIBP2 RAPGEF4 MYO1B COL18A1 CTNNBL1 PLCE1

3.50e-0530324812M39040
CoexpressionHE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL

SNX4 DLGAP5 SIGLEC5 MCM4 SCRN1 MCM6 BCKDHA VPS16 HSPA13 FANCA ALMS1 KIF15 BRCA2 CD101 MKI67 NUP153 SENP5 WEE1 IARS1 GTSE1 NUP88 AGGF1 E2F8 CSE1L OXCT1 TSR1 CHTF18 ESPL1 MMAB FILIP1L

3.53e-05142324830M45722
CoexpressionPUJANA_CHEK2_PCC_NETWORK

SNX4 MAT2A DLGAP5 MCM4 MCM6 BLMH SMG7 BRCA2 MKI67 HSPA4 NUP153 PNN WEE1 IARS1 GTSE1 NUP88 CSE1L TSR1 ESPL1 SNRPD2

4.18e-0576124820M11961
CoexpressionBLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN

BCOR ITPR1 DOCK6 PLXNA2 CFAP36 MLXIP C2CD2 WDR74 TSR1

4.63e-051752489M34029
CoexpressionBLALOCK_ALZHEIMERS_DISEASE_DN

SNX4 MAN1A1 USP9X ZNF184 MCM4 AASDHPPT PSMD12 ITPR1 HSPA13 PLCL2 PCDH11X NUP153 RALB VSNL1 SRSF5 FN1 PNN IARS1 RAPGEF4 RANBP9 UBA3 CCNG2 CSE1L OXCT1 LAMTOR3 ZNF75D SNRPD2

5.78e-05124824827M17728
CoexpressionGRYDER_PAX3FOXO1_TOP_ENHANCERS

GBF1 MYO9B MAT2A BCOR BRCA2 OS9 MYO18B PLXNA2 HSPG2 GPR107 TLE1 CTNNBL1 ADAMTS14 PDZRN3

8.79e-0544124814M172
CoexpressionLEE_EARLY_T_LYMPHOCYTE_UP

DLGAP5 MCM4 SCRN1 KIF15 MKI67 E2F8 PALLD

9.18e-051112487M7357
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL

GAMT DLGAP5 MCM4 MCM6 BCOR FANCA ALMS1 KIF15 BRCA2 PLCL2 MKI67 EEFSEC WEE1 GTSE1 LDLR E2F8 CCNG2 CSE1L OXCT1 CHTF18 ESPL1 MMAB

9.39e-0593924822M45768
CoexpressionHE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL

MAN1A1 MYO9B DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 PLCL2 MKI67 PNMA3 FAT3 GTSE1 LDLR GREB1 ESPL1

1.10e-0456724816M45692
CoexpressionTOOKER_GEMCITABINE_RESISTANCE_UP

BDH2 BMP4 HSPA4 RRP8 WDR74 PALLD

1.13e-04802486M19654
CoexpressionGSE3982_MAST_CELL_VS_BASOPHIL_UP

BCKDHA PSMD12 ACTN3 CD101 NRBP1 IARS1 MLXIP FAM171A1 WDR74

1.15e-041972489M5438
CoexpressionGSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP

MAT2A PTK2 BLMH MKI67 RALB GTSE1 DVL3 CCNG2 ESPL1

1.20e-041982489M8407
CoexpressionGSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP

ACTN3 CHGB ARMCX4 CLCC1 KATNIP RRP8 OXCT1 PRKN MYOM2

1.24e-041992489M8351
CoexpressionHALLMARK_MITOTIC_SPINDLE

MYO9B DLGAP5 ARHGEF11 ALMS1 KIF15 BRCA2 RANBP9 ESPL1 PALLD

1.24e-041992489M5893
CoexpressionGSE3982_EOSINOPHIL_VS_MAC_DN

SERBP1 MYO6 MCM4 BCKDHA DMXL1 C3 GALNT12 CSE1L ATP2B4

1.24e-041992489M5403
CoexpressionGSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN

ZNF180 AASDHPPT TRIP12 ITPR1 HSPA13 NUP153 WEE1 LDLR ESPL1

1.29e-042002489M4529
CoexpressionGSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP

MAN1A1 MKI67 TXNDC16 AGGF1 LDLR SNRPD2 CDH9 PDZRN3 RPL7A

1.29e-042002489M3979
CoexpressionGSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN

MYO6 EHD3 NFRKB C14orf119 PNN ATP10A TSR1 SLC15A4 LAMTOR3

1.29e-042002489M6251
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP

DLGAP5 MCM4 MCM6 FANCA BRCA2 MKI67 FN1 WEE1 GTSE1 LDLR TAMM41 CHTF18 GJC3 ESPL1 PALLD PDZRN3

1.38e-0457824816M2368
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HPROGBP

MYLK DLGAP5 BDH2 MCM6 KIF15 BRCA2 MKI67 WEE1 FAT3 GTSE1 PDZRN3

1.46e-0430024811M39059
CoexpressionFISCHER_DREAM_TARGETS

MAT2A ZNF184 DLGAP5 MCM4 MCM6 FANCA ALMS1 KIF15 BRCA2 MKI67 NUP153 PNN WEE1 GTSE1 NUP88 LDLR E2F8 CSE1L GTF3C2 CHTF18 LNPK ESPL1

1.47e-0496924822M149
CoexpressionPUJANA_ATM_PCC_NETWORK

MYF6 SNX4 SERBP1 MAT2A OBSCN MCM4 MCM6 BLMH SMG7 COL21A1 SCN2B PLCL2 MKI67 PPIP5K2 NOS2 HSPA4 NUP153 SENP5 PNN KHNYN GTSE1 RANBP9 AGGF1 UBA3 RRP8 CCNG2 CDK13 ESPL1

1.48e-04139424828M9585
CoexpressionKOBAYASHI_EGFR_SIGNALING_24HR_DN

DLGAP5 MCM4 MCM6 KIF15 MKI67 PNN GTSE1 E2F8 CSE1L ESPL1

1.60e-0425324810M16010
CoexpressionBENPORATH_CYCLING_GENES

DLGAP5 MCM4 MCM6 ITPR1 HSPA13 FANCA MKI67 C4B VPS37C SRSF5 PNN GTSE1 E2F8 AFAP1 PATJ ESPL1 LRIF1

1.62e-0464824817M8156
CoexpressionMEBARKI_HCC_PROGENITOR_FZD8CRD_UP

DLGAP5 SCRN1 FANCA KIF15 BRCA2 MKI67 REXO5 WEE1 GTSE1 E2F8 CCNG2 LIG3 PPP2R2C CSE1L CRACDL ESPL1

1.67e-0458824816M38992
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

MYO6 USP9X DLGAP5 PSMD12 DMXL1 ITPR1 KIF15 MKI67 PPIP5K2 DHX29 PNN CFAP36 IARS1 AGGF1 MPHOSPH8 QSER1 PALLD

1.87e-0465624817M18979
CoexpressionGARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN

ARMCX4 KIF15 MKI67 E2F8 ESPL1

1.88e-04562485M19590
CoexpressionHOUNKPE_HOUSEKEEPING_GENES

SERBP1 GBF1 AASDHPPT PSMD12 VPS16 TRIP12 UBA1 SUPT6H OS9 C14orf119 DHX29 HSPA4 NUP153 SENP5 EEFSEC NRBP1 VPS37C RANBP9 AGGF1 MORC2 ERGIC3 TSR1 CTNNBL1 HMGXB3

1.97e-04112924824M42508
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP

DLGAP5 MCM4 MCM6 FANCA BRCA2 MKI67 FN1 WEE1 GTSE1 LDLR TAMM41 CHTF18 GJC3 ESPL1 PALLD PDZRN3

1.98e-0459724816MM1309
CoexpressionHE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL

GAMT DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 REXO5 WEE1 GTSE1 E2F8 CSE1L CHTF18

2.03e-0447824814M45785
CoexpressionCHIN_BREAST_CANCER_COPY_NUMBER_DN

INS FANCA CDH13

2.23e-04132483M8845
CoexpressionGSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN

BCOR BRCA2 PNN RAPGEF4 SI QSER1 PATJ FILIP1L

2.25e-041702488M2942
CoexpressionDARWICHE_PAPILLOMA_PROGRESSION_RISK

SIGLEC5 MCM4 TCHHL1 KIF6 SIGLEC14 XDH

2.44e-04922486MM503
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

RTEL1 DLGAP5 MCM4 SCRN1 MCM6 CHGB FANCA ALMS1 BRCA2 PTPRN MKI67 PPIP5K2 GTSE1 E2F8 TH PPP2R2C OXCT1

2.84e-0468024817MM456
CoexpressionHOUNKPE_HOUSEKEEPING_GENES

SERBP1 GBF1 AASDHPPT PSMD12 VPS16 TRIP12 UBA1 SUPT6H OS9 C14orf119 DHX29 HSPA4 NUP153 SENP5 EEFSEC NRBP1 VPS37C RANBP9 AGGF1 MORC2 ERGIC3 TSR1 CTNNBL1 HMGXB3

2.86e-04115824824MM1338
CoexpressionBENPORATH_ES_1

SERBP1 USP9X MAT2A DLGAP5 MCM4 MCM6 ACTN3 HSPA4 VSNL1 PNN CSE1L EPHA1

2.86e-0437924812M1871
CoexpressionDESCARTES_ORGANOGENESIS_CARDIAC_MUSCLE_LINEAGES

OBSCN CD101 MYO18B VSNL1 CORO6 RNF207 PALLD ALPK2

3.57e-041822488MM3637
CoexpressionODONNELL_TFRC_TARGETS_DN

DLGAP5 TOX4 BRCA2 MKI67 VSNL1 GTSE1 ANKRD50

3.69e-041392487M6451
CoexpressionROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER

DLGAP5 MCM4 KIF15 MKI67 GTSE1 E2F8 ESPL1

3.85e-041402487M15664
CoexpressionHE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL

ERBB4 DLGAP5 MCM4 MCM6 KIF15 MKI67 WEE1 GTSE1 FILIP1L

3.88e-042322489M45800
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

SERBP1 USP9X ZNF180 ZNF184 MDGA2 ARMCX4 CLCC1 ALMS1 KIF15 BRCA2 MKI67 TXNDC16 HSPA4 CACNA1A ATN1 PNN CFAP36 FAT3 GTF2IRD1 LDLR GPR107 GRIP1 AFAP1 OXCT1 MPHOSPH8

1.10e-0583124325Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

ERBB4 OBSCN PLCL2 MYO18B PRKN MYOM2 PATJ RNF207 PALLD PDZRN3 ALPK2 CDH13

7.74e-10189248125e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

ERBB4 OBSCN PLCL2 MYO18B PRKN MYOM2 PATJ RNF207 PALLD PDZRN3 ALPK2 CDH13

8.22e-1019024812fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellTracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DLGAP5 TRIM29 FANCA KIF15 BRCA2 MKI67 VSNL1 DSG3 WEE1 GTSE1 E2F8 ESPL1

1.32e-0919824812f088badb90c6c2d916195f5649eda102119c9ac6
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 OXCT1 CHTF18 ESPL1

1.48e-092002481299acc1ea01288efdd5b166aa20d66735f2bbe543
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

ERBB4 OBSCN DYSF MYO18B GTF2IRD1 GRIP1 AGBL4 MYOM2 PALLD ALPK2 PLCE1

9.35e-09188248116d249fe92d51a19da19ec14bb2262d394255d577
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 DYSF FANCA KIF15 BRCA2 MKI67 HSPG2 GTSE1 RAPGEF4 E2F8 CDH13

1.04e-081902481131de1727822e9818652946dfb962daee77ffad68
ToppCellLV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

ERBB4 OBSCN PLCL2 MYO18B PRKN MYOM2 PATJ RNF207 PALLD PDZRN3 CDH13

1.04e-0819024811de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCellLA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper

ERBB4 OBSCN DYSF MYO18B GTF2IRD1 GRIP1 AGBL4 MYOM2 PALLD ALPK2 CDH13

1.10e-08191248115d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO6 MDGA2 DYSF MYCBPAP EHD3 CASKIN2 ADGRF5 RAPGEF4 ANKRD50 FAM171A1 ATP2B4

1.23e-0819324811a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

ERBB4 OBSCN MYO18B OXCT1 PRKN MYOM2 PATJ ATP2B4 PALLD PDZRN3 ALPK2

1.23e-0819324811dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

ERBB4 OBSCN MYO18B GRIP1 AGBL4 PRKN MYOM2 PALLD PDZRN3 ALPK2 CDH13

1.30e-0819424811c3535f7cc0076653c72db582047cff053c322397
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

ERBB4 OBSCN MYO18B GTF2IRD1 PRKN MYOM2 PATJ ATP2B4 PALLD PDZRN3 ALPK2

1.37e-081952481175fc81bddb246dca3b437fb60827b1d4fe416405
ToppCellSigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass

GBF1 PTK2 KIF15 BRCA2 MKI67 QSOX2 CD177 GTSE1 C2CD2 E2F8 ESPL1

1.77e-08200248114e489ecf472857357d45e9f6c7a812aa48b72ebf
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ACTN3 DYSF SH2D4B EHD3 KIF15 ADGRF5 MYO18B MMP15 REXO5 RAPGEF4

2.38e-0816024810830e3ef8c9708d25872c3052a0b2682fa9372111
ToppCell367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 TKTL1 KIF15 BRCA2 MKI67 GTSE1 NSUN7 CHTF18 CRACDL CDH13

5.57e-08175248100b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

DLGAP5 KIF15 MKI67 CD177 WEE1 GTSE1 RAPGEF4 E2F8 CGREF1 GJC3

5.57e-081752481016d4e97271df1db9a0d167fc82a90d84d20dd1f2
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DLGAP5 KIF15 MKI67 CD177 WEE1 GTSE1 RAPGEF4 E2F8 CGREF1 GJC3

5.57e-0817524810553e68e8b439a2293efb969e1e2aa017ceb80daf
ToppCellBAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

DLGAP5 KIF15 MKI67 CD177 WEE1 GTSE1 RAPGEF4 E2F8 CGREF1 GJC3

5.57e-0817524810289d2aa7164bc02b1876b99f2fb67baa8e030c4e
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MYLK MDGA2 ADGRF5 FN1 ATP10A C2CD2 RAB7B PALLD PDZRN3 PLCE1

8.48e-0818324810667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DLGAP5 MCM4 FANCA KIF15 MKI67 GTSE1 E2F8 ZNF252P-AS1 CHTF18 ESPL1

8.92e-0818424810eaef1dcde60ba14e2c7fd699d01c225487256d82
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DLGAP5 MCM4 FANCA KIF15 MKI67 GTSE1 E2F8 ZNF252P-AS1 CHTF18 ESPL1

8.92e-0818424810bba0138c8f7e3645a688b9a4d12f6f2134ee2c08
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DLGAP5 MCM4 FANCA KIF15 MKI67 GTSE1 E2F8 ZNF252P-AS1 CHTF18 ESPL1

8.92e-0818424810fa73738350654066d7f9ebf78359e20ee6cbdd98
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 MCM4 KIF15 KCNH2 MKI67 GTSE1 GTF2IRD1 E2F8 CHTF18 ESPL1

1.09e-0718824810f5102e8d95506c25c675094b86162a6a50087b64
ToppCellRV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper

ERBB4 OBSCN PLCL2 MYO18B MYOM2 PATJ PALLD PDZRN3 ALPK2 CDH13

1.15e-07189248109c1debd65c13d63fd4f3158917d621b44b714c26
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

OBSCN MYO18B GTF2IRD1 PRKN MYOM2 ATP2B4 PALLD PDZRN3 ALPK2 CDH13

1.15e-07189248100a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO6 MDGA2 DYSF MYCBPAP EHD3 CASKIN2 ADGRF5 RAPGEF4 FAM171A1 CDH13

1.20e-0719024810474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCellRV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper

ERBB4 OBSCN MYO18B GTF2IRD1 PRKN MYOM2 ATP2B4 PALLD ALPK2 CDH13

1.20e-071902481093c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

ERBB4 OBSCN PLCL2 MYO18B PRKN MYOM2 PATJ PALLD PDZRN3 CDH13

1.27e-071912481025f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCellPCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ERBB4 DLGAP5 KIF15 MKI67 GTSE1 NSUN7 E2F8 GRIP1 AGBL4 ESPL1

1.27e-071912481039220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

ERBB4 OBSCN PLCL2 MYO18B MYOM2 PATJ PALLD PDZRN3 ALPK2 CDH13

1.33e-0719224810ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCellfacs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO7A INS CHGB ARMCX4 EHD3 ADGRF5 HSPG2 MLXIP FAM171A1 ATP2B4

1.39e-07193248108084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCellmild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 ESPL1

1.53e-07195248109a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCell390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

MCM4 MCM6 KIF15 CD101 MKI67 QSOX2 WEE1 GTSE1 CHTF18 EPHA1

1.61e-071962481036ed1918f70b6f5760bb088b15ce422998055cc7
ToppCellHealthy-T/NK_proliferative|Healthy / disease group, cell group and cell class

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 ESPL1

1.61e-071962481091e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCellsevere_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2)

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 CHTF18

1.77e-0719824810ed86b0247006befe55400c287d334d2202b470bd
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9

DLGAP5 MCM4 PSMD12 KIF15 MKI67 RABIF GTSE1 E2F8 CSE1L ESPL1

1.77e-0719824810880f9817f5145f10f29fc05c5866090433532fe2
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DLGAP5 KIF15 BRCA2 MKI67 NOS2 WEE1 RPRML FAT3 GTSE1 E2F8

1.77e-07198248107225a6194c52b01c581e58d3cda107c4af96dc4f
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-071992481011c3d9fe811a4619347f47d2b0e94066e3085625
ToppCellLeuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 OXCT1

1.85e-071992481087113d398585076ece86b9098781e817f8ca241b
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-071992481036c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-0719924810bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 MCM4 FANCA KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 ESPL1

1.85e-0719924810a99516a5760f49a69b0fe45a9b2316e393252966
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-07199248107beb0e07a27fea94674f24eb61c381b0de38ed3e
ToppCellCOVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-07199248109f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCellCOVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-0719924810ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCellLPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

DLGAP5 KIF15 BRCA2 MKI67 REXO5 WEE1 GTSE1 E2F8 CHTF18 ESPL1

1.85e-0719924810be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCellmild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2)

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.85e-0719924810df2fcaf01b1b48632f84e7355ef21d20853f0664
ToppCellMild/Remission-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

MAN1A1 DLGAP5 SEC11C MCM4 MCM6 KIF15 MKI67 GTSE1 E2F8 ESPL1

1.85e-07199248101dda6116de639140c2d6f5012b7ab9ad0f737ae1
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class

DLGAP5 MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.94e-07200248106126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCellControl-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class

TRERF1 GBF1 DLGAP5 MCM4 KIF15 MKI67 CACNA1A E2F8 CSE1L CHTF18

1.94e-0720024810118321ac443feb42aee171baccfc4610f00a8822
ToppCellCOVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 GTSE1 E2F8 OXCT1 ESPL1

1.94e-0720024810f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 ESPL1

1.94e-07200248108f8b8c225cdc79baf16fe04be89bdb65e404a055
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 ESPL1

1.94e-0720024810a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed
ToppCellSevere-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

MAN1A1 DLGAP5 SEC11C MCM4 MCM6 KIF15 MKI67 GTSE1 E2F8 CSE1L

1.94e-07200248106d0cd00e52568d23597cc2a4059bd967d7d2dab5
ToppCellCOVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 GTSE1 E2F8 OXCT1 ESPL1

1.94e-072002481004bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCellSepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class

DLGAP5 MCM4 MCM6 KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 OXCT1

1.94e-0720024810093e97395be23092229521cc55aaaee8befbc149
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 KIF15 BRCA2 CD101 MKI67 REXO5 GTSE1 E2F8 GDPD4

2.53e-0715724891ccb07a38d3fb606ee5fbc0437655f49baaaa62c
ToppCell390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 ACTN3 CHGB KIF15 MKI67 GTSE1 E2F8 ADAMTS14 ESPL1

3.66e-071642489ad508f53009efdd1dae7abcdb5431387f3f7e7b2
ToppCell390C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 ACTN3 CHGB KIF15 MKI67 EVC2 GTSE1 E2F8 ESPL1

3.85e-071652489a5c3af634d2698f9a01cf074791756b7669f9fff
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 MCM4 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

4.05e-0716624892642544070564debe2deb2938d2c33997bf5ef02
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP5 FANCA KIF15 BRCA2 MKI67 WEE1 GTSE1 E2F8 ESPL1

4.71e-071692489e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell390C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

MCM4 MCM6 KIF15 BRCA2 MKI67 GTSE1 CHTF18 ESPL1 EPHA1

5.46e-0717224896fcc16f1067672967ecbcdfdc727649ae9891dd9
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 FANCA KIF15 BRCA2 MKI67 REXO5 GTSE1 E2F8 ESPL1

5.74e-071732489a25459b8140b0dbcb73e3b4cc1407b679229f25c
ToppCelldroplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SIGLEC5 UNC93A ACTN3 FHIP1B OS9 KIAA2012 FAT3 E2F8 TCP11L2

5.74e-071732489889a880de5fc19d26b82cfef3067869a28ef17ca
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SIGLEC5 UNC93A ACTN3 FHIP1B OS9 KIAA2012 FAT3 E2F8 TCP11L2

5.74e-07173248953e97835d7a518c278e7b90a0734eb0095d6aa33
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 KIF15 BRCA2 MKI67 FN1 GTSE1 E2F8 ESPL1 CDH13

6.02e-071742489c26eac176e9b0cba385630fdc60e0314a4e4caac
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MCM4 DYSF BRCA2 MKI67 NOS2 REXO5 GTSE1 ESPL1 CDH13

6.95e-07177248973ba0f0b4b33f10e9f036d6d9befa48a1258e682
ToppCellDividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

RTEL1 DLGAP5 KIF15 BRCA2 MKI67 GTSE1 E2F8 CHTF18 ESPL1

7.28e-0717824891893fadac2ec3d5de0a641e57b7b2f962012a9ba
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

MCM4 MCM6 FANCA KIF15 BRCA2 MKI67 GTSE1 CHTF18 ESPL1

7.63e-07179248988d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DLGAP5 MCM4 MCM6 FANCA KIF15 MKI67 GTSE1 E2F8 CHTF18

8.00e-07180248942f48e646fc6e72ad3cce72409ace3a0b64020a2
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MCM4 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 AGBL4 ESPL1

8.00e-071802489f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DLGAP5 MCM6 KIF15 BRCA2 PRR19 MKI67 GTSE1 PCDHB3 SERPINC1

8.37e-07181248973b1b59810f60e3e39ca1d5073a5a0d4f5377e6e
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CASKIN2 SCN2B ARHGEF37 SENP5 RAPGEF4 MYO1B CGREF1 SLC15A4 TRIM56

8.37e-071812489709e9c7a60d5f98635b99895ce30bb87a9f7376d
ToppCellnormal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass

MKI67 IQCE RAPGEF4 GTF2IRD1 GRIP1 SMG8 ESPL1 ALPK2 FILIP1L

8.37e-071812489b55dbcfae8c92d322071906831489830a22239b9
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

MYO6 CASKIN2 PCDH11X ADGRF5 DOCK6 NOS2 PLXNA2 RAPGEF4 CDH13

8.37e-071812489c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellControl-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations)

CYP2A6 CYP2A7 ERBB4 MYO6 PTK2 ADGRF5 LDLR GRIP1 PATJ

8.37e-071812489c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCelldroplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP5 MCM6 KIF15 MKI67 CCDC116 GTSE1 E2F8 CHTF18 SERPINC1

8.77e-07182248911494a66d986297b837332ee9d382b71b9f22591
ToppCellAdult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor

MAT1A ODAD4 LRGUK SPATA17 TTLL10 KIAA2012 DNAH9 KIF6 AGBL4

8.77e-0718224897ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCellmild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)

DLGAP5 MCM4 MYCBPAP SPATA17 KIF15 MKI67 GTSE1 E2F8 ESPL1

9.18e-071832489df8568751205313d149939ea2683097e3652a60b
ToppCellCOVID-cycling-|COVID / Condition, Cell_class and T cell subcluster

DLGAP5 MCM4 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.00e-061852489eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

OBSCN COL21A1 MYO18B PRKN MYOM2 PATJ PALLD PDZRN3 CDH13

1.00e-0618524896baccb26f999145e51b91d94315bf8d4655bef31
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 FANCA KIF15 BRCA2 MKI67 REXO5 GTSE1 E2F8 ESPL1

1.00e-06185248930e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCellAdult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor

ODAD4 LRGUK SPATA17 COL21A1 TTLL10 KIAA2012 DNAH9 KIF6 AGBL4

1.00e-06185248930f4980dee6cd5959655f8d74049f3bfb5312611
ToppCellCOVID-cycling|COVID / Condition, Cell_class and T cell subcluster

DLGAP5 MCM4 FANCA KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.00e-0618524895112f966735fa48f0606adcfd5c0212ad5d3d77a
ToppCellControl-Epithelial-Club|World / Disease state, Lineage and Cell class

CYP2A6 CYP2A7 ERBB4 MYO6 PTK2 ADGRF5 MYO1B LDLR PATJ

1.05e-0618624899798428691408e17ff2af2fe2d1b345f074d67e4
ToppCellFetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ODAD4 MYCBPAP LRGUK SPATA17 TTLL10 KIAA2012 DNAH9 KIF6 AGBL4

1.10e-0618724899e10ed56090d82589bc457788282f664b70ace4b
ToppCellLV-10._Endothelium_II|World / Chamber and Cluster_Paper

BCOR PCDH11X ADGRF5 DOCK6 PLXNA2 HSPG2 ATP10A TLE1 CDH13

1.10e-0618724897876dcb4800c2e54874df3d933efb79307a64a97
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 FANCA KIF15 BRCA2 MKI67 REXO5 GTSE1 E2F8 ESPL1

1.10e-0618724899351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCellEpithelial-ciliated_cell|World / Lineage, Cell type, age group and donor

ODAD4 MYCBPAP LRGUK SPATA17 TTLL10 KIAA2012 DNAH9 KIF6 AGBL4

1.15e-06188248961a459f3fe57e5728efc72637ff2edc2d343492b
ToppCellEndothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4)

BMP4 CACNA1A HSPG2 FN1 COL18A1 ATP2B4 PALLD CDH13 FILIP1L

1.15e-0618824892777eb7689b271c199021fe7d9db88ccebff14de
ToppCell3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue

DLGAP5 LAMP5 KIF15 MKI67 CCDC116 GTSE1 E2F8 RAB7B ESPL1

1.15e-061882489723348a1836a074e068320cb736ce6a953e0038f
ToppCellRA-10._Endothelium_II|RA / Chamber and Cluster_Paper

ITPR1 ADGRF5 DOCK6 PLXNA2 HSPG2 FN1 RAPGEF4 COL18A1 TLE1

1.20e-061892489c81787a8c662db5d7814c583dd64562857629e81
ToppCellAdult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor

ODAD4 MYCBPAP LRGUK SPATA17 TTLL10 KIAA2012 DNAH9 KIF6 AGBL4

1.20e-061892489b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell(02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint

MCM4 MCM6 KIF15 MKI67 GTSE1 E2F8 CSE1L CHTF18 ESPL1

1.25e-06190248953f017a11ca5ebe9025558e12cedc409cab2e5aa
ToppCell3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue

CYP2A7 DLGAP5 MCM4 KIF15 BRCA2 MKI67 GTSE1 E2F8 ESPL1

1.31e-061912489e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 MDGA2 ADGRF5 FN1 MYO1B ATP10A C2CD2 TLE1 FILIP1L

1.31e-0619124897b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TRERF1 MDGA2 ADGRF5 FN1 MYO1B ATP10A C2CD2 TLE1 FILIP1L

1.31e-061912489cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

MYLK MDGA2 COL21A1 MYO1B ATP10A C2CD2 PALLD FILIP1L PLCE1

1.37e-06192248924e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCelldroplet-Pancreas-Exocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYLK B3GNT8 MKI67 ADGRF5 NOS2 HSPG2 FN1 E2F8 CDH13

1.37e-061922489a42aed9e563f5f4af029b8804c104f11ad227a8f
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

MAN1A1 ITPR1 VSNL1 FAT3 AGBL4 PPP2R2C CRACDL SLIT1 GABRA3

1.37e-0619224895c7e8b80b44d9ce55c797cdf8267ac5382e26cac
Drugblebbistatin

MYLK MYO6 MYO7A MYO9B PTK2 MYO18B CACNA1A FN1 MYO1B EPHA1

5.41e-0711624610CID003476986
DrugPHEMA

DLGAP5 PTK2 FN1 PNN DSG3 COL18A1 MMAB

9.21e-07492467CID000013360
Drug2'-methoxyacetophenone

CYP2A6 CYP2A7 CYP2A13

1.25e-0632463CID000068481
DrugColchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A

RTEL1 MYO9B ITPR1 SCN2B VSNL1 ATN1 DVL3 GALNT12 MYO1B AFAP1 ATP2B4 PALLD

1.43e-06194246123213_UP
DrugTropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A

ARHGEF11 PTK2 TOX4 CASKIN2 SUPT6H KATNIP DOCK6 WEE1 MYO1B GPR107 COL18A1 LRP6

1.78e-06198246126264_DN
DrugMeclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A

GAMT RTEL1 TRIM29 KCNH2 DOCK6 KPNA5 DVL3 MLXIP CCNG2 LIG3 CDK13 ATP2B4

1.87e-06199246124982_UP
DrugMethylcholanthrene

TRERF1 CYP2A7 MYLK MYO7A MAT1A DLGAP5 BDH2 MCM4 MCM6 PSMD12 PTK2 ITIH3 ITPR1 EHD3 MKI67 C3 C4A C4B WEE1 GTSE1 XDH E2F8 GDPD4 CCNG2 MYOM2 GREB1 ESPL1 CDH13 GABRA3

2.71e-06103424629ctd:D008748
Drugresveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

DLGAP5 FANCA NFRKB MKI67 MMP15 IQCE WEE1 GTSE1 C2CD2 E2F8 ESPL1

3.78e-0617724611841_DN
Drugepoxiconazole

ERBB4 MDGA2 PSMD12 ITIH3 HSPA13 MKI67 C4B CACNA1A RAPGEF4 MYO1B LDLR C2CD2 GRIP1 SLIT1 PRKN

5.04e-0634124615ctd:C109476
DrugRisperidone

ERBB4 INS CHGB KCNH2 DVL3 LDLR TH

6.45e-06652467ctd:D018967
DrugMiconazole

CYP2A13 ERBB4 PTPRN KCNH2 NOS2 LIG3 PRKN

6.45e-06652467ctd:D008825
Drugolanzapine

INS KCNH2 C3 C4A C4B FN1 RAPGEF4 LDLR TH

6.85e-061212469ctd:C076029
Drugcolcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA

PTK2 KATNIP FN1 KHNYN MYO1B RRP8 GTF2IRD1 LDLR CCNG2 TLE1 PALLD

7.45e-06190246111103_UP
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MYO6 MCM4 HSPA13 TOX4 HSPA4 RALB FN1 RANBP9 MYO1B YTHDC2 CCNG2

8.23e-06192246116223_DN
Drug0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A

ARHGEF11 ITPR1 CASKIN2 NFRKB MMP14 HSPG2 ATN1 SRSF5 CCNG2 GTF3C2 PATJ

8.23e-06192246114334_DN
DrugMuramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A

MYO9B ARHGEF11 CASKIN2 SUPT6H MMP15 CACNA1A VPS37C HSPG2 ATN1 PPFIBP2 COL18A1

8.64e-06193246113262_UP
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A

RTEL1 MYO7A ITPR1 CASKIN2 SENP5 COL18A1 AFAP1 LRP6 HMGXB3 MPHOSPH8 PDZRN3

9.08e-06194246112221_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A

MAN1A1 FANCA ALMS1 BRCA2 SUPT6H DOCK6 RABIF IQCE NUP88 MYO1B GTF3C2

1.00e-05196246111794_DN
DrugMafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A

RTEL1 EHD3 ALMS1 BRCA2 ADGRF5 DOCK6 AGGF1 AFAP1 CGREF1 ZNF75D HMGXB3

1.05e-05197246112124_DN
DrugGossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A

PDE4A GAMT RTEL1 MYO9B TRIM29 CASKIN2 MKI67 ATN1 TLE1 GREB1 EPHA1

1.10e-05198246114762_DN
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

RTEL1 MYO9B ARHGEF11 TYK2 ALMS1 MMP15 ATN1 GREB1 PATJ EPHA1 FILIP1L

1.10e-05198246116976_UP
DrugProcaine hydrochloride [51-05-8]; Down 200; 14.6uM; HL60; HT_HG-U133A

MAN1A1 ARHGEF11 PTPRA SMG7 PLCL2 C3 RABIF YTHDC2 LDLR TSR1 CGREF1

1.10e-05198246111838_DN
DrugCimetidine [51481-61-9]; Up 200; 15.8uM; HL60; HG-U133A

MYO9B PTK2 FANCA BRCA2 RABIF RALB FN1 AGGF1 ATP10A LDLR GPR107

1.15e-05199246111964_UP
DrugNomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A

PDE4A ARHGEF11 ALMS1 MMP15 IQCE FN1 WEE1 MYO1B LIG3 CTNNBL1 ZNF75D

1.15e-05199246117217_DN
Drug2,4,5,2',5'-pentachlorobiphenyl

CYP2A6 MAN1A1 ZNF184 DLGAP5 MCM4 MCM6 BRWD3 ITPR1 FANCA KIF15 BRCA2 PCDH11X MKI67 ADGRF5 ARHGEF37 NOS2 CCDC116 PLXNA2 FN1 MYO1H FAT3 GTSE1 DVL3 MYO1B MLXIP E2F8 AFAP1 KNDC1 GREB1 QSER1 MRAP2 ESPL1 MMAB ATP2B4

1.50e-05144124634ctd:C009828
DrugCurcumin

MYLK INS BCOR PTK2 ITPR1 KCNH2 MKI67 C3 C4B MMP14 NOS2 HSPA4 CCDC116 LILRB3 SRSF5 FN1 XDH ANKRD50 LDLR SCRN2 LIG3 TH LRP6 FILIP1L

1.86e-0585024624ctd:D003474
DrugAC1NUV4X

TRERF1 AASDHPPT PTK2 FN1

2.19e-05162464CID005494443
DrugHaloperidol

ERBB4 PDE4A INS KCNH2 CACNA1A HSPG2 RALB VSNL1 RAPGEF4 DVL3 LDLR TH LAMTOR3 SNRPD2

2.33e-0534224614ctd:D006220
Drugphenytoin

CYP2A6 CYP2A13 INS ASIC3 ITPR1 KCNH2 SCN2B MKI67 NOS2 CACNA1A LGI3

2.81e-0521924611CID000001775
Drugpurealin

MYLK MYO6 MYO9B MYO18B DNAH9 MYO1B

3.79e-05582466CID006419303
Druglomustine; Down 200; 100uM; PC3; HT_HG-U133A

PTK2 ITPR1 KIF15 PLCL2 NFRKB C3 RALB E2F8 LIG3 ESPL1

4.01e-05188246107050_DN
DrugGinkgolide A [15291-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A

MAN1A1 MCM4 PTK2 PTPRA HSPA4 RALB RANBP9 AGGF1 CCNG2 TLE1

4.20e-05189246104121_DN
DrugPHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A

MYLK TRIM29 CASKIN2 SUPT6H NFRKB MMP14 ATN1 SRSF5 ZNF75D EPHA1

4.79e-05192246104330_DN
DrugMethylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A

MAN1A1 MYO9B NFRKB MMP14 AGGF1 YTHDC2 CCNG2 CDK13 CTNNBL1 GREB1

5.01e-05193246104113_DN
Drugtrifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A

MYO9B FANCA KCNH2 MMP15 HSPA4 RABIF DVL3 GALNT12 WDR74 LRP6

5.01e-05193246105584_DN
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A

FANCA SUPT6H C3 MMP14 DOCK6 HSPG2 DVL3 MYO1B CDK13 ZNF75D

5.01e-05193246104322_UP
DrugFurazolidone [67-45-8]; Down 200; 17.8uM; MCF7; HT_HG-U133A

GAMT MYO9B ASIC3 ITPR1 SMG7 PLCL2 C3 MMP14 MMP15 MLXIP

5.23e-05194246104178_DN
DrugH-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A

MCM4 PTK2 BMP4 SUPT6H NFRKB HSPA4 PNMA3 DVL3 LDLR GTF3C2

5.46e-05195246106921_DN
DrugPhenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A

FANCA KCNH2 MMP15 HSPA4 HSPG2 DVL3 LIG3 GTF3C2 TSR1 TLE1

5.46e-05195246104360_DN
DrugMetoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A

RTEL1 MYO9B ASIC3 ARHGEF11 CASKIN2 KCNH2 DVL3 LIG3 KDM7A GREB1

5.70e-05196246106846_DN
DrugPergolide mesylate [66104-23-2]; Up 200; 9.8uM; PC3; HT_HG-U133A

GBF1 RTEL1 HSPA13 SMG7 SUPT6H REXO5 GPR107 CCNG2 TH LRP6

5.70e-05196246107271_UP
DrugCanavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A

ZNF184 AASDHPPT PPIP5K2 HSPA4 RALB RANBP9 E2F8 GPR107 CCNG2 LAMTOR3

5.70e-05196246104782_DN
Drug2,4,4'-trichlorobiphenyl

MAN1A1 ZNF184 DLGAP5 MCM4 MCM6 BRWD3 ITPR1 FANCA KIF15 BRCA2 PCDH11X MKI67 ADGRF5 ARHGEF37 CCDC116 PLXNA2 FN1 MYO1H FAT3 GTSE1 DVL3 MYO1B MLXIP E2F8 AFAP1 KNDC1 GREB1 QSER1 MRAP2 ESPL1 MMAB ATP2B4

5.87e-05141124632ctd:C081766
DrugFoliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A

MAN1A1 GBF1 TRIM29 CASKIN2 SUPT6H HSPG2 ATN1 FN1 LIG3 CDK13

5.95e-05197246104295_DN
DrugPiperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A

GAMT LAMP5 HSPA4 SENP5 VPS37C FN1 PPFIBP2 MORC2 CSE1L TSR1

5.95e-05197246101327_UP
DrugPantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; HL60; HT_HG-U133A

PTK2 TOX4 NFRKB C3 OTUD3 RALB WEE1 AGGF1 GTF2IRD1 CDK13

5.95e-05197246101311_DN
DrugAC1L3VEW

FANCA C4A SI LIG3 LNPK

6.03e-05392465CID000122872
DrugDinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A

FANCA KCNH2 CD101 MMP14 HSPG2 PPFIBP2 GALNT12 AFAP1 CDK13 ATP2B4

6.21e-05198246105409_UP
Drug2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A

MYO7A ITPR1 FANCA KCNH2 NFRKB C3 HSPG2 MORC2 LIG3 AFAP1

6.21e-05198246105422_UP
DrugMilrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A

PDE4A MAN1A1 MYO9B MCM4 TYK2 SMG7 FN1 LIG3 POLI LRP6

6.21e-05198246107210_DN
DrugPiperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A

GBF1 MYO9B ITPR1 PTPRA KATNIP MMP15 LIG3 LRP6 ATP2B4 EPHA1

6.21e-05198246103551_DN
DrugBupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; HL60; HT_HG-U133A

GAMT ARHGEF11 SUPT6H OTUD3 MMP14 IQCE NRBP1 PPFIBP2 GTF2IRD1 LIG3

6.48e-05199246102404_DN
DrugDelsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A

ZNF180 ARHGEF11 FANCA MMP15 FN1 MYO1B CCNG2 COL18A1 CSE1L LRP6

6.48e-05199246107212_DN
DrugClopamide [636-54-4]; Up 200; 11.6uM; HL60; HG-U133A

MYF6 RTEL1 TRIM29 PTK2 FANCA PTPRN CD101 CACNA1A COL18A1 KDM7A

6.48e-05199246101605_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

ZNF184 EHD3 PPIP5K2 HSPA4 RABIF IQCE PNN AGGF1 E2F8 PATJ

6.48e-05199246106923_DN
DrugEtidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; PC3; HT_HG-U133A

MAN1A1 ITPR1 SMG7 NFRKB MMP14 MYO1B GPR107 LIG3 CGREF1 LRP6

6.48e-05199246104564_DN
DrugAmiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MAN1A1 PTK2 OTUD3 MMP14 MMP15 DVL3 LIG3 TLE1 HMGXB3 PATJ

6.75e-05200246103339_DN
DrugLinuron

ERBB4 MDGA2 BMP4 CACNA1A GRIP1 SLIT1 PRKN MYOM2

7.77e-051282468ctd:D008044
Drugmercury

INS CLCC1 ITIH3 ITPR1 BLMH KCNH2 SUPT6H OS9 NOS2 CACNA1A EVC2 FN1 DSG3 MYO1B GTF2IRD1 MYOM2 ATP2B4

9.21e-0554224617CID000023931
Drugdexamethasone 21-acetate

BCKDHA LNPK EPHA1

9.98e-0592463CID000003680
Drugpropargyl ether

CYP2A6 CYP2A13

1.16e-0422462ctd:C531209
DrugnM HP

BLMH CACNA1A

1.16e-0422462CID003569560
DrugHempa

CYP2A6 CYP2A13

1.16e-0422462ctd:D006492
Drugtert-butylbenzene

MAT1A C4A

1.16e-0422462CID000007366
Drugnicotine imine

CYP2A6 CYP2A13

1.16e-0422462ctd:C034629
Drugalpha-nicotyrine

CYP2A6 CYP2A13

1.16e-0422462ctd:C008615
DrugN-nitrosoguvacoline

CYP2A6 CYP2A13

1.16e-0422462ctd:C036676
Drug2-amino-4-methylthio-3-butenoic acid

MAT1A MAT2A

1.16e-0422462ctd:C083253
DrugMethamphetamine

GBF1 MYLK MYO7A DLGAP5 OBSCN ASIC3 DYSF UBA1 KIF15 SUPT6H MKI67 ADGRF5 MYO18B PPIP5K2 DOCK6 NOS2 CCDC116 RABIF HSPG2 EVC2 FN1 CD177 XDH C2CD2 TH CHTF18 LGI3 KNDC1 CORO6 PALLD CDH13

1.21e-04140124631ctd:D008694
Drug2,3-bis(3'-hydroxybenzyl)butyrolactone

TRERF1 MYO6 DLGAP5 MCM4 MCM6 DMXL1 ITPR1 BRCA2 COL21A1 MKI67 ARHGEF37 GTSE1 MYO1B GTF2IRD1 LDLR E2F8 AFAP1 CSE1L OXCT1 TLE1 GREB1 QSER1 ESPL1 FILIP1L

1.27e-0496124624ctd:C029497
Drugresveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

DLGAP5 KIF15 MKI67 PNN GTSE1 C2CD2 E2F8 LIG3 ESPL1

1.32e-041762469958_DN
DrugMG-262; Down 200; 0.1uM; MCF7; HT_HG-U133A

MAN1A1 MKI67 WEE1 GTSE1 E2F8 CCNG2 CGREF1 ESPL1 EPHA1

1.32e-0417624697063_DN
Drugvanadyl

ERBB4 PDE4A MYO7A INS SIGLEC5 VPS16 PTK2 TYK2 PTPRA DNAH9 FN1 LRP6

1.38e-0430724612CID000061671
Drug3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone

PLXNA2 GRIP1 CDH13

1.41e-04102463ctd:C054121
Drug1,7-dimethyluric acid

CYP2A6 PTPRN XDH

1.41e-04102463CID000091611
Drug5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA

MAN1A1 DLGAP5 BMP4 MKI67 GTSE1 LDLR E2F8 CSE1L ESPL1

1.50e-041792469904_DN
DrugN-ethylmaleimide

ERBB4 MYO6 MYO9B INS MAT1A MAT2A VPS16 BLMH PTPRA KIF15 MYO18B HSPA4 FN1 MYO1B POLI ATP2B4

1.51e-0451124616CID000004362
Drugclenbuterol

MYF6 MYO6 MYO9B INS ASIC3 MYO18B RAPGEF4 MYO1B

1.60e-041422468CID000002783
DrugPodophyllotoxin [518-28-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A

MAN1A1 RTEL1 SENP5 HSPG2 LDLR CCNG2 LIG3 AFAP1 FILIP1L

1.77e-0418324697198_UP
DrugMonensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A

MYO9B KCNH2 C3 ATN1 FN1 LDLR CCNG2 ZNF75D PATJ

1.77e-0418324693704_UP
DrugMephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A

HSPG2 ATN1 FN1 YTHDC2 MLXIP LIG3 AFAP1 CDK13 QSER1

1.92e-0418524694707_UP
DrugAmethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A

DLGAP5 PTK2 MKI67 GTSE1 LDLR WDR74 GREB1 ESPL1 LRIF1

1.99e-0418624695000_DN
DrugAlbuterol

PDE4A INS NOS2 FN1 LDLR

2.01e-04502465ctd:D000420
DrugThioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A

PTK2 PTPRA BRCA2 MKI67 LDLR LRP6 HMGXB3 ESPL1 ATP2B4

2.08e-0418724694989_DN
DrugAlprostadil [745-65-3]; Up 200; 11.2uM; PC3; HT_HG-U133A

TRIM29 ITPR1 BMP4 C3 MMP14 MMP15 ATN1 SRSF5 LIG3

2.25e-0418924694099_UP
DrugEstradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A

PTK2 FANCA BRCA2 NFRKB MMP14 SENP5 KPNA5 CDK13 LRP6

2.34e-0419024696718_DN
DrugEthisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A

BMP4 PLXNA2 ATN1 PPFIBP2 XDH FAM171A1 LIG3 AFAP1 CGREF1

2.43e-0419124693975_DN
DrugImipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

RTEL1 BCKDHA ITPR1 CASKIN2 KCNH2 RABIF MORC2 GPR107 PATJ

2.53e-0419224692873_DN
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A

MAN1A1 GAMT SMG7 ALMS1 YTHDC2 CDK13 ZNF75D KDM7A GREB1

2.53e-0419224694743_DN
DrugClobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A

MAN1A1 MCM4 TOX4 HSPA4 MYO1B LIG3 CDK13 MPHOSPH8 GREB1

2.62e-0419324696835_DN
DrugVincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A

ASIC3 TRIM29 ITPR1 NFRKB MMP14 ATN1 SRSF5 GALNT12 CCNG2

2.73e-0419424694341_DN
DrugPirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

MYO9B C3 PPFIBP2 YTHDC2 MORC2 LIG3 AFAP1 GREB1 PATJ

2.73e-0419424693316_DN
Drug5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA

GAMT MCM4 ITPR1 PTPRA NFRKB DOCK6 CCNG2 CDK13 GREB1

2.73e-041942469898_UP
DrugCP-645525-01 [287190-82-3]; Up 200; 10uM; MCF7; HT_HG-U133A

ARHGEF11 TOX4 NFRKB HSPA4 RABIF LDLR CCNG2 CDK13 QSER1

2.73e-0419424697522_UP
DrugMoxalactam disodium salt [64953-12-4]; Down 200; 7uM; PC3; HT_HG-U133A

BCKDHA ARHGEF11 PTK2 ITPR1 NFRKB MMP14 PLXNA2 CCNG2 LIG3

2.73e-0419424694648_DN
DrugHarmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A

RTEL1 ASIC3 ARHGEF11 EHD3 ALMS1 IQCE SRSF5 GPR107 ATP2B4

2.73e-0419424692900_DN
DrugAzaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A

SNX4 MAN1A1 BCKDHA PTPRA ALMS1 CASKIN2 RANBP9 CCNG2 ATP2B4

2.83e-0419524697444_DN
DrugAmpyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A

MAN1A1 ASIC3 ARHGEF11 ALMS1 SRSF5 DVL3 LRP6 PATJ ATP2B4

2.83e-0419524696845_DN
DrugGallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A

DYSF DOCK6 IQCE SENP5 CACNA1A ATN1 CCNG2 LIG3 CSE1L

2.83e-0419524696215_UP
DrugHomosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A

MYO6 MYO9B SUPT6H SENP5 REXO5 LIG3 CSE1L LRP6 PATJ

2.83e-0419524694533_DN
Diseasebody fat percentage

MAN1A1 TRIP12 FANCA SPATA17 KCNU1 MMP15 KIAA2012 NUP88 MIB2 JAKMIP3 AGBL4 CSE1L PATJ ATP2B4 FILIP1L PLCE1

2.31e-0648823616EFO_0007800
Diseaseaspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement

TRIP12 FANCA KCNU1 MMP15 KIAA2012 NUP88 MIB2 JAKMIP3 AGBL4 PATJ ATP2B4 FILIP1L PLCE1

8.46e-0636423613EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Diseaseuremia (biomarker_via_orthology)

PTK2 NOS2 TH

5.82e-05102363DOID:4676 (biomarker_via_orthology)
Diseaseovarian cancer (is_implicated_in)

MYO6 FANCA BRCA2 PRKN CDH13

8.59e-05562365DOID:2394 (is_implicated_in)
Diseasemelanoma (is_implicated_in)

RTEL1 BMP4 BRCA2 KDM7A

1.53e-04342364DOID:1909 (is_implicated_in)
Diseaseaortic measurement

MDGA2 COL21A1 HSPA4 RPRML MORC2 COL18A1 AFAP1 CDH13 PLCE1

2.03e-042512369EFO_0020865
DiseaseMalignant Glioma

MYLK RTEL1 TRIM29 DMXL1 BRCA2

2.49e-04702365C0555198
Diseasemixed gliomas

MYLK RTEL1 TRIM29 DMXL1 BRCA2

2.49e-04702365C0259783
Diseasepancreatic cancer (is_implicated_in)

INS FANCA BRCA2 MKI67 LIG3 PALLD

2.90e-041122366DOID:1793 (is_implicated_in)
Diseasecomplement factor H measurement

CYP2A6 ERBB4 NSUN7 CDH13

3.20e-04412364EFO_0008097
Diseaseage at onset, Parkinson disease

DSG3 PRKN QSER1

3.77e-04182363EFO_0004847, MONDO_0005180
Diseaselevel of cobalamin binding intrinsic factor in blood serum

MAN1A1 VPS37C

3.78e-0442362OBA_2041717
Diseasecolorectal cancer (is_implicated_in)

ERBB4 BCOR MKI67 TRPV3 GALNT12 CTNNBL1

4.39e-041212366DOID:9256 (is_implicated_in)
Diseasesmoking behavior, body mass index

ERBB4 SEC11C NXPE2 AGBL4 PRKN PATJ

4.79e-041232366EFO_0004318, EFO_0004340
DiseaseBipolar Disorder

ERBB4 PDE4A INS ITIH3 ITPR1 BRCA2 HSPA4 CACNA1A TH PPP2R2C TLL2 GABRA3

5.01e-0447723612C0005586
Diseasephosphatidylcholine measurement

PTK2 DOCK6 NRBP1 VPS37C KIF6 MYO1H LDLR AGBL4 SNRPD2

5.02e-042842369EFO_0010226
Diseasemucositis (biomarker_via_orthology)

MKI67 NOS2

6.27e-0452362DOID:0080178 (biomarker_via_orthology)
DiseaseCardiac Arrest

INS KCNH2

6.27e-0452362C0018790
DiseaseDystonia

GAMT MAT1A CACNA1A TH PRKN

6.45e-04862365C0013421
DiseaseGlioma

MYLK RTEL1 TRIM29 DMXL1 BRCA2

6.80e-04872365C0017638
DiseaseNeoplastic Cell Transformation

CYP2A13 PTK2 KCNH2 MMP14 NOS2 FN1

9.11e-041392366C0007621
DiseaseJT interval

GBF1 OBSCN COL21A1 KCNH2 LIG3 CDK13 MYOM2 RNF207

9.12e-042482368EFO_0007885
Diseasediabetic angiopathy (implicated_via_orthology)

NOS2 FN1

9.35e-0462362DOID:11713 (implicated_via_orthology)
Diseasemitral valve annular diameter

ERBB4 RPRML

9.35e-0462362EFO_0020096
Diseasemigraine with aura (is_implicated_in)

TRPV3 CACNA1A

9.35e-0462362DOID:10024 (is_implicated_in)
Diseasepneumocystosis (biomarker_via_orthology)

C3 NOS2

9.35e-0462362DOID:11339 (biomarker_via_orthology)
Diseaseresponse to peginterferon alfa-2a

SPATA17 ATP10A PRKN

1.02e-03252363EFO_0010103
DiseaseBrain Diseases

CYP2A6 MAT1A TH

1.02e-03252363C0006111
Diseaseelectrocardiography

OBSCN PTK2 KCNH2 MYO18B MMP15 YTHDC2 LIG3 RNF207 PALLD PDZRN3 CDH13 PLCE1

1.24e-0353023612EFO_0004327
DiseaseAutistic Disorder

PDE4A C4B NOS2 XDH ATP10A PRKN CDH9 GABRA3

1.26e-032612368C0004352
DiseaseEncephalopathies

CYP2A6 MAT1A TH

1.28e-03272363C0085584
Diseasearabinose measurement

ERBB4 CDH13

1.30e-0372362EFO_0021030
Diseasesubstance-related disorder (implicated_via_orthology)

KCNU1 CDH13

1.30e-0372362DOID:303 (implicated_via_orthology)
Diseasebrain connectivity measurement

ERBB4 DYSF FANCA COL21A1 PLXNA2 KIF6 FAT3 GTSE1 GALNT12 AFAP1

1.52e-0340023610EFO_0005210
Diseasesystemic lupus erythematosus (is_implicated_in)

C3 C4A C4B SNRPD2

1.55e-03622364DOID:9074 (is_implicated_in)
Diseasefamilial atrial fibrillation

ERBB4 PTK2 KCNH2 MYO18B HSPG2 AGBL4

1.65e-031562366C3468561
DiseasePersistent atrial fibrillation

ERBB4 PTK2 KCNH2 MYO18B HSPG2 AGBL4

1.65e-031562366C2585653
DiseaseParoxysmal atrial fibrillation

ERBB4 PTK2 KCNH2 MYO18B HSPG2 AGBL4

1.65e-031562366C0235480
Diseaseprostate cancer (is_marker_for)

ERBB4 MYO6 INS PTK2 MMP15 CDK13

1.65e-031562366DOID:10283 (is_marker_for)
DiseaseColorectal Carcinoma

CYP2A6 OBSCN BMP4 PCDH11X MKI67 TTLL10 EVC2 FN1 GALNT12 MYO1B LIG3 CSE1L ERGIC3 EPHA1

1.67e-0370223614C0009402
Diseasepsoriasis

PDE4A SCRN1 TYK2 PLCL2 NOS2 MLXIP SLIT1 POLI

1.68e-032732368EFO_0000676
Diseaseacetoacetate measurement

MLXIP OXCT1

1.73e-0382362EFO_0010111
Diseasebipolar II disorder

OXCT1 SLIT1

1.73e-0382362EFO_0009964
DiseaseCytotoxic Cerebral Edema

MYLK NOS2

1.73e-0382362C0472388
DiseaseVasogenic Cerebral Edema

MYLK NOS2

1.73e-0382362C0472387
DiseaseVasogenic Brain Edema

MYLK NOS2

1.73e-0382362C0750969
DiseaseCytotoxic Brain Edema

MYLK NOS2

1.73e-0382362C0750970
DiseaseVentricular Fibrillation

INS KCNH2

1.73e-0382362C0042510
DiseaseBrain Edema

MYLK NOS2

1.73e-0382362C1527311
DiseaseCerebral Edema

MYLK NOS2

1.73e-0382362C0006114
DiseaseAtrial Fibrillation

ERBB4 PTK2 KCNH2 MYO18B HSPG2 AGBL4

1.87e-031602366C0004238
Diseasenon-high density lipoprotein cholesterol measurement

CYP2A6 PDE4A TYK2 BRCA2 QSOX2 CACNA1A FN1 MYO1H LDLR AGBL4 CSE1L ERGIC3 TAMM41 PLCE1

1.93e-0371323614EFO_0005689
DiseasePancreatic carcinoma, familial

BRCA2 PALLD

2.21e-0392362C2931038
Diseaseanterior uveitis (biomarker_via_orthology)

C3 NOS2

2.21e-0392362DOID:1407 (biomarker_via_orthology)
Diseasedisease free survival, type 1 diabetes mellitus

INS TH

2.21e-0392362EFO_0000409, MONDO_0005147
DiseaseProstate cancer, familial

MYO9B BRCA2 MMP14 PPFIBP2

2.30e-03692364C2931456
DiseaseChronic Obstructive Airway Disease

MMP14 NOS2 EEFSEC

2.31e-03332363C0024117
Diseasecolorectal adenoma

FAT3 C2CD2 CDH13

2.31e-03332363EFO_0005406
DiseaseComplement deficiency disease

C3 C4A C4B

2.31e-03332363C0272242
DiseaseChronic Airflow Obstruction

MMP14 NOS2 EEFSEC

2.31e-03332363C1527303
Diseasehypertension (biomarker_via_orthology)

PTK2 C3 NOS2 HSPG2 FN1 XDH TH

2.44e-032272367DOID:10763 (biomarker_via_orthology)
DiseaseGrey matter density measurement

KATNIP MYO1B MRAP2

2.52e-03342363EFO_0010306
DiseasePolydactyly

USP9X BMP4 ALMS1 EVC2 GRIP1

2.54e-031172365C0152427
Diseasecardiomyopathy (implicated_via_orthology)

ERBB4 XDH COL18A1 PRKN

2.55e-03712364DOID:0050700 (implicated_via_orthology)
DiseaseMalignant neoplasm of breast

TRERF1 ERBB4 OBSCN TRIM29 DYSF BMP4 BRCA2 MKI67 MMP14 SPOCD1 DNAH9 NOS2 KPNA5 KIF6 FN1 DVL3 XDH JAKMIP3

2.65e-03107423618C0006142
DiseaseLiver carcinoma

MAT1A DLGAP5 PTK2 ITIH3 EHD3 KIF15 MKI67 GTSE1 E2F8 TH CDH13

2.73e-0350723611C2239176
Diseasedolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement

SIGLEC5 SIGLEC14

2.75e-03102362EFO_0801544
Diseaseresponse to hydrochlorothiazide, diastolic blood pressure change measurement

COL21A1 OXCT1

2.75e-03102362EFO_0005202, EFO_0006945
Diseasetooth agenesis (is_implicated_in)

BMP4 LRP6

2.75e-03102362DOID:0050591 (is_implicated_in)
DiseaseFanconi anemia (is_implicated_in)

FANCA BRCA2

2.75e-03102362DOID:13636 (is_implicated_in)
Diseaselung cancer (is_implicated_in)

RTEL1 MAT2A CCDC116 DVL3

2.96e-03742364DOID:1324 (is_implicated_in)
Diseasecervical cancer (is_marker_for)

ERBB4 PTK2 PRKN

2.97e-03362363DOID:4362 (is_marker_for)
Diseaseretinal vasculature measurement

ERBB4 MCM6 DYSF ITPR1 TTLL10 DNAH9 HSPG2 CSE1L PATJ PALLD PLCE1

3.17e-0351723611EFO_0010554
Diseasegastric adenocarcinoma (is_implicated_in)

RTEL1 PLCE1

3.34e-03112362DOID:3717 (is_implicated_in)
DiseaseN-acetylhistidine measurement

ALMS1 TRIM56

3.34e-03112362EFO_0800022
DiseaseBarrett's esophagus (is_marker_for)

BMP4 MKI67

3.34e-03112362DOID:9206 (is_marker_for)
Diseasesystemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus

TYK2 SMG7 CCDC116

3.47e-03382363EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915
Diseasedilated cardiomyopathy (is_marker_for)

OBSCN MMP14 NOS2

3.73e-03392363DOID:12930 (is_marker_for)
Diseasehypertension (implicated_via_orthology)

MYO6 INS PTK2 FN1 XDH

3.74e-031282365DOID:10763 (implicated_via_orthology)
DiseaseNeoplasm Invasiveness

MYLK INS PTK2 MMP14 FN1 RNF207

3.75e-031842366C0027626
Diseaseautosomal dominant cerebellar ataxia (implicated_via_orthology)

ITPR1 PPP2R2C

3.99e-03122362DOID:1441 (implicated_via_orthology)
Diseasesialic acid-binding Ig-like lectin 14 measurement

SIGLEC5 SIGLEC14

3.99e-03122362EFO_0008284
DiseasePathological accumulation of air in tissues

NOS2 PPP2R2C

3.99e-03122362C0013990
DiseaseParkinson Disease, Secondary Vascular

NOS2 PRKN

3.99e-03122362C0751414
DiseaseAtherosclerotic Parkinsonism

NOS2 PRKN

3.99e-03122362C0751415
DiseaseSecondary Parkinson Disease

NOS2 PRKN

3.99e-03122362C0030569
Diseasenicotine metabolite ratio

CYP2A6 CYP2A7

3.99e-03122362EFO_0007794
Diseaseevent free survival time, type 1 diabetes mellitus, autoantibody measurement

INS TH

3.99e-03122362EFO_0000482, EFO_0004866, MONDO_0005147
Diseasebone density

HSPA13 BMP4 SPATA17 MINDY4 CTNNBL1 PATJ ESPL1 LRIF1 CDH13

4.23e-033882369EFO_0003923
DiseaseAmino Acid Metabolism, Inherited Disorders

GAMT MAT1A

4.69e-03132362C0750905
DiseaseAmino Acid Metabolism, Inborn Errors

GAMT MAT1A

4.69e-03132362C0002514
Diseasewaist-hip ratio

ERBB4 MAN1A1 MYO9B PSMD12 TRIP12 SPATA17 ADGRF5 MINDY4 DOCK6 HSPA4 FN1 TWIST2 YTHDC2 AGBL4 COL18A1 PATJ ATP2B4 CDH13 PLCE1

4.75e-03122623619EFO_0004343
DiseaseFEV/FEC ratio

ZNF184 SEC11C PTK2 ITPR1 BMP4 KIF15 COL21A1 MMP15 HSPA4 EEFSEC HSPG2 GALNT12 GTF2IRD1 CCNG2 AGBL4 AFAP1 RAB7B KDM7A PDZRN3

4.83e-03122823619EFO_0004713
Diseaseskin melanoma (is_implicated_in)

FANCA BRCA2

5.44e-03142362DOID:8923 (is_implicated_in)
DiseaseNeoplasm of lung

CYP2A6 PRKN

5.44e-03142362cv:C0024121
DiseaseLung cancer

CYP2A6 PRKN

5.44e-03142362cv:C0242379
DiseaseLUNG CANCER

CYP2A6 PRKN

5.44e-03142362211980
DiseaseT wave morphology measurement

KCNH2 RNF207

5.44e-03142362EFO_0008398
Diseaseabdominal aortic aneurysm (biomarker_via_orthology)

MMP14 NOS2

5.44e-03142362DOID:7693 (biomarker_via_orthology)
DiseaseFanconi anemia

FANCA BRCA2

5.44e-03142362cv:C0015625

Protein segments in the cluster

PeptideGeneStartEntry
NKSRAAEPTVDQRLG

CACNA1A

836

O00555
AAREEQPEKDFFGRV

CHTF18

906

Q8WVB6
VEENPFVSRRKNGDL

ERBB4

1166

Q15303
DAFLREREDQLVPGQ

EPHA1

711

P21709
GRVVIFQREPESKNA

PPP2R2C

46

Q9Y2T4
AVRSIQPEEKERIGQ

AASDHPPT

36

Q9NRN7
QPEEKERIGQFVFAR

AASDHPPT

41

Q9NRN7
GEQEPIFRKREFNKE

CCDC116

261

Q8IYX3
GDGRSPEFRENEQKR

CTNNBL1

541

Q8WYA6
FQDEGAEPLKQRVEA

C4B

1156

P0C0L5
IDRVIGKNRQPKFED

CYP2A6

331

P11509
VFPVSQKRGTIENER

ALPK2

1581

Q86TB3
PSAEELRRQAGLNKD

ARHGEF37

571

A1IGU5
RAAIEVNAGRKPQAI

AFAP1

596

Q8N556
NQSIEPLGRKVERSE

CFAP36

221

Q96G28
ERSVKLAQEGRAPVE

ATN1

836

P54259
QADDRVVINKPESAG

ALMS1

2226

Q8TCU4
RFDGPAREELQQVAA

ARHGEF11

816

O15085
EQEERFQPREKGLSL

CCNG2

26

Q16589
QDGEQRISLPESLKR

C3

276

P01024
FQRLVPGRENCKDEQ

BRWD3

601

Q6RI45
PGTDRTENVKYRQVD

AGGF1

151

Q8N302
ARTNEIDNDGRIPFI

ANKRD50

871

Q9ULJ7
QIGIFSAREKRDVQP

CD177

386

Q8N6Q3
EGSEQKIPEATNRRV

SERPINC1

66

P01008
QRQPFPRDVGKVVDS

CDH13

151

P55290
AKGQVEARRESLDPV

CGREF1

191

Q99674
ANVEDLEPVRNLFRK

DHX29

541

Q7Z478
ERVTLADFKGVLQRP

DVL3

26

Q92997
AELRLFREQVDQGPD

BMP4

156

P12644
PEARRLIVNKNAGET

BCOR

1451

Q6W2J9
EKPDGLINEATRQVA

CBWD5

181

Q5RIA9
AEEEVGPRKGDFTRQ

CAMSAP3

966

Q9P1Y5
SLVEEGEKQNKRFRP

DMXL1

2381

Q9Y485
AGQEAEKRRVFSLPQ

CDK13

111

Q14004
QVEALPDARDKSRGN

ARMCX4

441

Q5H9R4
LSGNPADLEKRRQVF

ATP2B4

66

P23634
IECEKPNNDLSRFRG

ATP10A

231

O60312
FIEPLERGQQEKEAS

ADAMTS14

186

Q8WXS8
PGVVQRFVKFLERNE

KPNA5

126

O15131
TENFVLPDDDRRGIQ

MMP14

266

P50281
RTKIQAQIDRFPIGD

RANBP9

346

Q96S59
VGNKSDLEERRQVPV

RALB

126

P11234
EIDPNSIAAKDGRIR

PDZRN3

451

Q9UPQ7
RLRFDQPDDFKGVNV

HSPG2

541

P98160
IDLADRKVPQEVAQG

RAB7B

126

Q96AH8
LQKFVPEIRDGQREF

QSER1

1391

Q2KHR3
ENFKGPDRELRTVRQ

QSOX2

156

Q6ZRP7
IFSRDEKVLGQSQEP

GPR107

146

Q5VW38
TPKTRREAEDLQVGQ

INS

51

P01308
KDRQIEQLLDPSRGT

IQCE

181

Q6IPM2
RFDVVPLVLQANGRD

NOS2

301

P35228
RAKVEFNIRKPNEGA

SERBP1

301

Q8NC51
FEIQTDPRTNEGILK

DSG3

316

P32926
APERQGEALRVKNAV

FHIP1B

911

Q8N612
QRFIDPLAKEEENVG

MCM4

171

P33991
VETKEQFQEAVPGRS

GJC3

251

Q8NFK1
TNPRFGGKELRDEEQ

MCM6

306

Q14566
RDQRPGLVRSKDQFE

PTPRN

946

Q16849
TVLSQPLFEKQDREG

FAM171A1

491

Q5VUB5
LTNGRIIKDERQPFA

KDM7A

581

Q6ZMT4
IQFPEDQKVRAGESV

MYLK

1241

Q15746
LGQPIKIRFQESEER

HSPA4

681

P34932
SNEGDAIKVFVRIRP

KIF15

21

Q9NS87
RRVFLKPAEENSGNA

LRIF1

6

Q5T3J3
RPSTGEEKRVFQEQE

NFRKB

511

Q6P4R8
FVSNEVPLEKGARNE

GREB1

1071

Q4ZG55
GQDVLEVVFSKPNRE

ITPR1

491

Q14643
KDPRVVTNLIDGVNR

KATNIP

1026

O60303
KNFDLRPGVIVRDLD

MAT2A

351

P31153
VDNFKLPEDDLRGIQ

MMP15

286

P51511
FRRRTDKDTEQPGEV

KCNH2

891

Q12809
QPSELVSAEGRNRKA

RABIF

6

P47224
EKPDGLINEATRQVA

CBWD2

181

Q8IUF1
EKPDGLINEATRQVA

CBWD1

181

Q9BRT8
FAIRNQIKLGEDPRV

HMGXB3

821

Q12766
LDVIQEPRIRVKFNG

PLXNA2

1066

O75051
EPRIRVKFNGKESVN

PLXNA2

1071

O75051
NVDENIRKLTGRDPN

PNN

21

Q9H307
EAFEALKRRTVANPN

MYF6

111

P23409
NIPRFGVKTDQEELL

PDE4A

351

P27815
FQGVIAELKVRRDPQ

COL18A1

631

P39060
PVPRQNGDRFIEEKT

FAM214A

131

Q32MH5
PDTIEQCRREGFSQK

ERGIC3

176

Q9Y282
PRDLADGFVNNKRES

KIF6

41

Q6ZMV9
REREGKAEPRLFSQE

KIAA2012

806

Q0VF49
GSPEQQLDEKDARRF

JAKMIP3

281

Q5VZ66
EGVQSVRQRLKDDAP

EVC2

801

Q86UK5
VLKGEQDRPRAVVVN

LRP6

1051

O75581
KNFDLRPGVIVRDLD

MAT1A

351

Q00266
TNPEKDIFVVRENGT

LAMP5

41

Q9UJQ1
ESRRQEPGDFVKQDI

GABRA3

31

P34903
DFDLKRTTNIGEVQP

GDPD4

246

Q6W3E5
EEELNPENKRFVITR

KCNU1

1006

A8MYU2
PENKRFVITRPANEF

KCNU1

1011

A8MYU2
DQRKTDFQRPAGAAE

LILRB3

476

O75022
GARSLQFRAEKERQP

LRGUK

26

Q96M69
RDNEETPFEVGIRVQ

ASIC3

226

Q9UHC3
GRSTEFRNIQKLPVE

MKI67

876

P46013
VDRLAGIINFQRPKD

PSMD12

406

O00232
QTGVIRPNISFDREK

PCDH11X

621

Q9BZA7
VEKEPGQRRALSVQA

LIG3

461

P49916
RGQEPVKQADFVRSK

CRACDL

866

Q6NV74
FTQDVRPEQLLEGKD

CASKIN2

476

Q8WXE0
KPEDPRSQGVERFIQ

GTSE1

106

Q9NYZ3
FNALIGPEAEQEKRE

PPFIBP2

781

Q8ND30
AVEPAFLEIRQGQDR

MDGA2

541

Q7Z553
NARTREPVTDNVEKF

MORC2

151

Q9Y6X9
KRREEVNQRNVPGID

NRBP1

66

Q9UHY1
KRNNAEENLEPSGRV

OTUD3

276

Q5T2D3
LPARFIEDVKNQEAR

OBSCN

3536

Q5VST9
PARFIEDVKNQEARE

OBSCN

3801

Q5VST9
PRFIQKLRSQEVAEG

PALLD

271

Q8WX93
RGRQVLLKPQVSEDD

MLXIP

16

Q9HAP2
RRAQAPGNLEEFEVN

ESPL1

701

Q14674
QREVTVQKGPLFRAE

CD101

21

Q93033
NDLVFLEQPEGSRRK

C2CD2

651

Q9Y426
IDRVIGKNRQPKFED

CYP2A13

331

Q16696
SPEIRNRDQKRGLFD

E2F8

71

A0AVK6
TQRERQKGLPRQVFE

DOCK6

141

Q96HP0
GEPSIKRNLLNEFDR

BRCA2

2281

P51587
NGRRISDPQVFSKEV

FILIP1L

786

Q4L180
LRDGQERDAPIVNKV

FN1

1156

P02751
IDRVIGKNRQPKFED

CYP2A7

331

P20853
GFQKNSDLRRTVEPE

FANCA

246

O15360
RFLRKPNVAEAGEQF

F8A1;

36

P23610
GPQRERFLEDLVAKA

C14orf119

51

Q9NWQ9
TRVQAVDPDIGINRK

FAT3

3151

Q8TDW7
EKPDGLINEATRQVA

CBWD3

181

Q5JTY5
EKPDGLINEATRQVA

CBWD6

181

Q4V339
PDNLREGAEQKVVFI

AGBL4

211

Q5VU57
DGKPGREFSEQFIRQ

COL21A1

781

Q96P44
KEVPSLERNEGRIAQ

DLGAP5

411

Q15398
RARLEPFGDVTERKQ

GALNT12

401

Q8IXK2
IIDPRKGQVVAEQAR

CORO6

201

Q6QEF8
TAQRKEPEDGRLVQF

BLMH

121

Q13867
VGFPVSQDQEREKRS

FDCSP

16

Q8NFU4
KVAQDQLRDKAPFRG

MAN1A1

156

P33908
DRDGVPVIKVANDNA

LAMTOR3

26

Q9UHA4
ETQVPALLEAGFRRE

GAMT

191

Q14353
EDFVDPNGKISLQRE

GBF1

1051

Q92538
PDRFAVSAEAENKVR

KHNYN

11

O15037
EVGFRPQRSVKAERA

KNDC1

1031

Q76NI1
IPRIRQVIQEFFGKD

HSPA13

411

P48723
DIRAQLPQDSKRFEG

DNAH9

1531

Q9NYC9
DPLVDESLKRQGFQE

GTF2IRD1

676

Q9UHL9
ALAVRRQSIPEEFKG

GRIP1

36

Q9Y3R0
LLAVKSEPGRFAERQ

B3GNT8

151

Q7Z7M8
DKETNRDFLPSGRIE

POLI

481

Q9UNA4
DQVKDRGPEATRRFF

SLC15A4

181

Q8N697
NENTKFEVRLLRDPA

CHGB

76

P05060
IDRKTGRQVEPESEF

CDH9

131

Q9ULB4
KPQDFQIRVQVIEGR

DYSF

216

O75923
FQDEGAEPLKQRVEA

C4A

1156

P0C0L4
VSENNRKREEIPLDF

MPHOSPH8

461

Q99549
FTGERRPKDDQVFEA

MMAB

71

Q96EY8
IRQEEVAGIRAKFPN

MAP1LC3C

21

Q9BXW4
KEARRRAVAENQPFL

BCKDHA

311

P12694
EFNRVIIPVKRGEEN

PTPRA

571

P18433
EEIRKTFQLNPITGD

PCDHB3

286

Q9Y5E6
GKPAELQRRVSADSQ

MIB2

241

Q96AX9
RLREGLKNQSPTEAE

NUP88

26

Q99567
EKRPNFVDRQASTVE

SMG8

731

Q8ND04
KIAERAQGELFPDRA

RTEL1

71

Q9NZ71
NRKQCQGPFRDITEV

SPATA17

236

Q96L03
VPGQEETVKNLEIFR

USP9X

321

Q93008
DIVALGQRSRDVPQK

RNF207

141

Q6ZRF8
FNTGDERAQKRQPIR

RAPGEF4

651

Q8WZA2
ERAQKRQPIRGSDEV

RAPGEF4

656

Q8WZA2
KLFGQETPEQREARI

SNX4

361

O95219
RRPIIQFVESGDDKN

TRIM29

76

Q14134
LTNFREDPIRAGEIV

SEC11C

81

Q9BY50
FLVQERRPSKDVGAA

RPRML

101

Q8N4K4
AKRQGVPADQLRVIF

PRKN

31

O60260
LQKREEEEFNTGPLS

SNRPD2

16

P62316
APVRDNDIRELKATG

TCP11L2

191

Q8N4U5
IPREIDQVAGDKNTA

NXPE2

431

Q96DL1
RKQPFQRAIGPEEEI

PLCE1

2076

Q9P212
IGQDIQPKRDLTRFV

RPL7A

41

P62424
AVIFAKNSDRPRDEV

SCRN2

26

Q96FV2
KNSDRPRDEVQEVVF

SCRN2

31

Q96FV2
GESRPEKIQENVRNA

ITIH3

401

Q06033
DRKFQTRVLSDNEEP

NSUN7

136

Q8NE18
RPDREFRVGIQKAQE

ODAD4

111

Q96NG3
QSFIIRPQKEGERAL

PTK2

356

Q05397
VIVKPRNSDGEFLNR

PNMA3

91

Q9UL41
GTENADVQKPRRSLE

PLCL2

1101

Q9UPR0
LNRFQPEGDLERLVA

PTCHD4

61

Q6ZW05
IKTREVNRDQGRSFP

SMG7

551

Q92540
NNPDRRVKPETQGRF

SIGLEC5

76

O15389
PVVRAENLRFKEEGV

IARS1

631

P41252
EIKENPFGIQIRRRS

SI

1066

P14410
AIASKPREVREFNGQ

OXCT1

181

P55809
GTDDRRRKDPEVFQT

EHD3

6

Q9NZN3
LVPGAEEAQKERQRQ

OS9

626

Q13438
VFIGRLNPAAREKDV

SRSF5

6

Q13243
LVVFGKNSARPRDEV

SCRN1

21

Q12765
ARGNPEEARNDFLKR

BDH2

191

Q9BUT1
PAGEEALRQKRAVAT

ADGRF5

41

Q8IZF2
RKDDPIGNLNTAFEV

ACTN3

211

Q08043
DQFKATLPEADRERG

ACTN3

566

Q08043
RDVDLRFQTGNKSPE

CLCC1

426

Q96S66
ERFQLRSIPVKGAED

SUPT6H

296

Q7KZ85
GRPKAEVAAEFLNDR

UBA3

121

Q8TBC4
KLERFQDRVEFSGNP

SCN2B

91

O60939
QGSEEPVFRAKNVRN

WDR74

161

Q6RFH5
LTEAREKNRPEFLQG

SENP5

681

Q96HI0
FDKQPQSRERGITLD

EEFSEC

36

P57772
TDKRRNGPEFSNDIK

TLE1

211

Q04724
PQDANVVFKRAEEGV

TXNDC16

316

Q9P2K2
GKREFDVRQTPQVNI

WEE1

221

P30291
KADPGRQESLQAEVI

TSR1

346

Q2NL82
RRPAEKFLESVEGNQ

CSE1L

26

P55060
NEDGLTPEQRVDKIF

VSNL1

141

P62760
ERLERAFKRQGSQPA

MINDY4

341

Q4G0A6
RPLEPDKVFSRQGNE

MRAP2

96

Q96G30
ERQRKQQGTKEFTFP

PRR19

226

A6NJB7
DVQPGSVADRDQRLK

PATJ

166

Q8NI35
RESRQAPNKLVGAAE

REXO5

16

Q96IC2
GVSETFKEQLLQEPR

REXO5

606

Q96IC2
QEELEAKAQPASRGR

SPOCD1

361

Q6ZMY3
EDVARAINQKLGDTP

VPS16

501

Q9H269
FLQPIRDVQRESEGE

UNC93A

221

Q86WB7
FLDTILPRQDDNGVR

TLL2

311

Q9Y6L7
PENEALRESGSQKAR

MYCBPAP

666

Q8TBZ2
DTPRKQLRFEGERVT

XDH

221

P47989
IRDFLEEANRVLKPG

RRP8

371

O43159
SVFVLGRTEEKQQEP

NUP153

1096

P49790
PGKNRDVEETLFQVA

TAMM41

266

Q96BW9
EDIGKNRAEVSQPRL

UBA1

121

P22314
LEKSRVARQPEGESN

MYO18B

741

Q8IUG5
EEPANGVKIERFTRD

ZNF180

131

Q9UJW8
PKTERGNVFAVEAEN

YTHDC2

146

Q9H6S0
FLQREPDGTKNEVTA

ZNF75D

126

P51815
LNEEAEVQRGFRPIA

ZNF252P-AS1

121

Q0IIN9
EDPGPVRRTDFNKIQ

TRPV3

751

Q8NET8
EEQLPRRAGFERNTK

SH2D4B

306

Q5SQS7
QEEKSPLFSVQREGL

GTF3C2

351

Q8WUA4
SRENEGRRPFKIDND

PPIP5K2

916

O43314
GEKNRALEAVVPAVR

TCHHL1

601

Q5QJ38
LAILRGFPTEAERQQ

TTC27

6

Q6P3X3
SENAIQAIPRKAFRG

SLIT1

141

O75093
INEDTGTARAIQRKP

TRIP12

786

Q14669
VVRKPRASQELAGDA

VPS37C

156

A5D8V6
QNPLLVDGRKFDVRS

TTLL10

366

Q6ZVT0
NNPDRRVKPETQGRF

SIGLEC14

76

Q08ET2
TPQERFEIGQAKVLR

TKTL1

456

P51854
DGVEDFRRQLPSQKT

TOX4

186

O94842
DPGQRDLFRDVTLEN

ZNF184

46

Q99676
FGPREILVADEQNRA

TRIM56

516

Q9BRZ2
RLRKFPIEQQDGAFV

TYK2

501

P29597
DVEPRINIGLRFQAE

TRERF1

776

Q96PN7
PQLEDVSRFLKERTG

TH

301

P07101
GTSEEELERQPKRFG

TWIST2

16

Q8WVJ9
LFRENGSKPRAIVVD

LDLR

511

P01130
RLPEFSFEKRQVVEG

LNPK

316

Q9C0E8
VRKPNDLEAFRIDGD

LGI3

326

Q8N145
EKSRVVKQPRGERNF

MYO1B

191

O43795
FVNSRIDEGDINPKV

MYO1H

866

Q8N1T3
TRKRGAEILPRQFEE

MYO6

1246

Q9UM54
GINERTKQRGDFPTD

MYO7A

1651

Q13402
VERGLLPRQQADFDD

MYO9B

136

Q13459
EAEFQRKEFLRKQGP

MYOM2

1116

P54296